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 SUMMARY 
The focus of this study was to investigate how the cytotoxic protein granulysin, which is 
released from cytotoxic T lymphocytes and natural killer cells, interacts with eukaryotic 
versus prokaryotic membranes, how it is able to bind to and enter an infected cell, as well as 
how it can reach and kill the intracellular bacteria without harming the host cell.  
Using surface plasmon resonance (SPR) and immunoblotting we found that granulysin binds 
to eukaryotic membranes using electrostatic interactions. The entering of granulysin through 
eukaryotic membranes can be explained by the reversible binding of granulysin on cholesterol 
enriched lipid raft microdomains on the host cell membrane. Granulysin is then taken up by 
the endocytotic pathway as we could show using confocal microscopy. The endocytotic 
compartments get more acidic in the later stages, promoting a pH dependent activity of 
granulysin, which we show by fluorescence release assays. Once granulysin reaches the 
phagosomes and lysosomes, where intracellular bacteria are located, it binds again and 
oligomerizes on the prokaryotic membranes, and finally permeabilizes the membrane, as we 
could show using atomic force microscopy (AFM). The oligomerization of granulysin was 
studied using fluorescence resonance energy transfer (FRET) techniques.  
This finding is of importance for understanding how granulysin and other positively charged 
antimicrobial proteins bind to the host cell membrane, are endocytosed and then capable to 
bind again to the bacterial membrane, leading to lysis of the intracellular bacteria. 
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 ZUSAMMENFASSUNG 
Ziel der vorgeliegenden Arbeit war die Interaktion des, von zytotoxischen T-Zellen und 
natürlichen Killer Zellen freigesetzten, Protein Granulysin mit pro- und eukaryotischen 
Membranen zu analysieren. Darüber hinaus wurde untersucht wie Granulysin über die 
Membran einer infizierten Zelle aufgenommen wird und nachfolgend intrazelluläre Bakterien 
erreicht um diese zu töten, jedoch ohne die Wirtszelle zu schädigen. 
Mit Oberflächen-Plasmon-Resonanz (SPR) und Immunoblotting konnten wir nachweisen, 
dass Granulysin durch elektrostatische Wechselwirkungen an eukaryotische Membranen 
bindet. Die Aufnahme von Granulysin durch die eukaryotische Membran kann durch eine 
reversible Bindung des Proteins an cholesterolhaltige Lipid Raft Mikrodomänen auf der 
Membranoberfläche erklärt werden. Durch konfokale Laserskanning Mikroskopie konnten 
wir nachweisen, dass Granulysin mittels Endozytose aufgenommen wird. Durch 
Fluorezenzfreisetzungstests konnten wir eine starke pH Abhängigkeit von Granulysin zeigen. 
Granulysin befindet sich nach der Aufnahme gelöst in endozytotischen Vesikeln, deren pH 
Wert im Laufe der Reifung abnimmt. Durch diesen pH Abnahmen wird die 
Bindungskapazität des Granulysins an Membran gefördert. Eine Verschmelzung der 
Granulysin beinhaltenden Endosomen mit Lysophagosomen, die intrazelluläre Bakterien 
enthalten können, führt zum Binden von Granulysin an die Membranen intrazellulären 
Prokaryoten. Da durch werden diese permeabilisiert, was wir mit Raster Kraft Mikroskopie 
(AFM) zeigen konnten. Es kommt hierbei zu einer Oligomerisierung der Granulysinmoleküle 
in der Prokaryotenmembran, was wir durch Fluoreszenz Resonanz Energietransfer (FRET) 
nachweisen konnten. 
Möglicherweise lässt sich Granulysin also Modellprotein für andere positiv geladene 
antimikrobische Proteine verstehen, die einen ähnlichen Wirkungmechanismus aufweisen 
könnten. Ob der Mechanismus der endozytotischen Aufnahme mit nachfolgender 
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 Oligomerisation in der Bakterienmembran universell für alle bakterienlysierenden Proteine 
gilt, werden nachfolgende Untersuchungen zeigen. 
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 IMMUNE RESPONSE AS DEFENCE AGAINST INTRA-
CELLULAR BACTERIAL INFECTIONS 
Humans have several mechanisms as defence against infections. The first line of defence is 
the mechanical anatomical barrier of the skin and internal epithelial layers. The second line 
comprises two systems that act in cooperation as protection against infections: the cell 
mediated innate immune response, which rapidly recognizes preserved molecular patterns on 
pathogens and the cell mediated adaptive immune response that relies on gene rearrangement 
and clonal expansion of antigen-specific lymphocytes (Litman, Cannon & Dishaw, 2005; 
Perregaux et al., 2002). The immune defence against intracellular bacteria is mediated by 
antibodies and cytotoxic T lymphocytes (CTLs) of the adaptive immune response as well as 
natural killer (NK) cells of the innate immune response (Flynn et al., 1993; Krensky, 2000; 
Liu, Walsh & Young, 1995b). The main focus of this study is directed on the defence against 
intracellular infections and the mechanism by which bacteria are killed by the immune 
system. 
Cell Mediated Immunity of the Innate Immune Response 
The cell mediated immunity of the innate immune response acts in response against 
intracellular bacterial infection. The leukocytes of the innate system include the NK cells, 
which are crucial in the antibacterial defence mechanism. NK cells release cytotoxic proteins 
resulting in death of infected cells as well as intracellular bacteria. Other processes are 
induced e.g. by mast cells that rapidly release granules containing histamine, heparin and 
chemokines as well as chemotaktic cytokines into the environment leading to attraction of 
leukocytes to the site of infection (Finlay & McFadden, 2006). Cytokines, such as IL-12, 
contribute to the proliferation and activation of NK cells (de Bruin et al., 2005; Hafner et al., 
1999; Shibakura et al., 2003). 
7
 Cytokines that activate the recruitment of leukocytes into tissue engage also the expression of 
endothelial adhesion molecules (E-selectin, P-selectin, ICAM-1 and VCAM-1) and specific 
chemoattractants such as chemokines (Bochner, 2000). The first step involves rolling of 
leukocytes on the endothelial surface, which is mainly mediated by the selectin family. 
Rolling is followed by adhesion, which is mediated by leukocyte β1 and β2 integrins binding 
to the adhesion molecules ICAM-1 and VCAM-1 (Bochner, 2000). After the migration 
through the endothelium, the chemokines in the tissue determine where the leukocytes will 
localize and finally lead to lysis and killing of the intracellular bacteria (Constantin et al., 
2000). 
Natural Killer Cells  
Natural killer (NK) cells (CD56+) are essential for the cellular aspect of the innate immunity. 
They respond to help in bacterial infections in an antigen-independent manner, before the 
development of the adaptive immune system (Harty, Tvinnereim & White, 2000; Smyth et al., 
2005). NK cells are able to distinguish between infected and malignant cells from normal host 
cells using receptors that recognize specific major histocompatibility complex (MHC) class I 
molecules. NK receptors are either member of the immunoglobulin (Ig) superfamily or of the 
C-type lectin superfamily. The activation of these receptors gives an inhibitory signal that 
does not induce NK mediated killing. Infection, but also transformation leads to reduced 
levels of MCH class I molecules, resulting in a higher probability of NK cell activity and 
leads therefore to killing of the pathogen (Smyth et al., 2005)  
NK cells kill malignant and infected host cells by releasing cytotoxic proteins, such as 
perforin, granzyme B and granulysin, from acidic granular compartments and also by binding 
of the receptors Fas and TRAIL-R on the target cell (Sato et al., 2001). This mechanism is 
similar to the killing mechanism of CTLs, and will be described later. 
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 Cell-Mediated Immunity of the Adaptive Immune Response 
The adaptive cell-mediated immunity is triggered by priming and activation of T cells by 
antigen presenting cells (APC). The maturation of the effective cell-mediated immune 
response requires a proper activation of the CTLs by APC in the secondary lymphoid organs, 
and also the migration of the responding T cells to the particular site of the antigen in the 
body. The effectiveness of the T cell activation in the lymphoid organs depends on the 
concentration of the peptide-antigen and also the affinity of the T cell receptor (TCR) towards 
the antigen/MHC complex (Deeths & Mescher, 1999).  
The integrin family and their ligands are important for the migration and activation of the 
CTLs. The most important integrin for CTLs is LFA-1 (lymphocyte function associated 
molecule) and its ligands, the intercellular adhesion molecules ICAM-1, ICAM-2 and ICAM-
3, which are particularly expressed on APCs. The antigen-independent binding between the 
APC and the CTL, which is assisted by LFA-1 and ICAMs, by increasing the capability of the 
T lymphocyte to detect antigenic complexes presented on APCs. The activation of the T cell 
through the TCR results in a conversion of the LFA-1 from a low-avidity state to a high-
avidity state for the binding of ICAMs (Jenkinson, Williams & Morgan, 2005; Kanwar et al., 
2003). 
After activation and maturation, these T cells are antigen-specific CTLs and they release 
various cytokines in response to each antigen, such as IL-2, the major interleukin inducing 
clonal T cell proliferation (Kanoh et al., 2002; Liu et al., 2002). Upon recognition of antigens, 
T cell differentiation finally results in migration to the site of the bacterial infection. The cell-
mediated immunity is directed primarily at microbes that survive in phagocytes and microbes 
that infect non-phagocytic cells (Horowitz, Friedlaender & Qian, 1996; White et al., 2000). 
9
 Cytotoxic T Lymphocytes 
The CTLs (CD8+, CD4+, NKT, γδ) are capable of inducing death of infected somatic or tumor 
cells and also damaged cells and to kill intracellular bacteria in infected cells (Renkvist et al., 
2001; Tynan et al., 2005). Most cytotoxic T cells express αβ-T-cell receptors that can 
recognize a specific antigen bound to MHC class I molecule, present on all nucleated cells, 
and a glycoprotein called CD8 in CD8+ T cells, which serves as a co-receptor specific for the 
MHC class I molecule (Hein et al., 1995; Iannacone et al., 2005; Malek, 2003). The T cell 
antigen receptor does not interact with native antigens, but it is specific for a form of the 
antigen that is presented in combination with the MHC class I molecule (Vitetta et al., 1989). 
The elimination of the infection using cellular mechanisms, is completed via production of 
cytokines (IFN-γ) or by cell mediated cytolysis releasing cytotoxic proteins (Kaspar et al., 
2001; Keefe et al., 2005; Sun et al., 2004). The mechanism by which these cytotoxic proteins 
are mediating target cell death is not completely understood, but it involves that perforin, one 
or more of the five human granzymes and/or granulysin are released from the granules of 
CTLs and NK cells. Perforin molecules associate with the membrane of the target cell by 
binding through the mannose 6-phosphate receptor, and by forming membrane pores. 
Through there pores, granzymes and granulysin have been thought to be able to enter the 
infected cell (Kaspar et al., 2001; Liu, Persechini & Young, 1995a; Liu et al., 1995b; Smyth et 
al., 2001). A second way to induce apoptosis is via cell-surface interactions between the 
cytotoxic T lymphocyte and the infected cell. When a cytotoxic T lymphocyte is activated it 
begins expressing the surface protein Fas ligand, which is able to bind Fas molecules 
expressed on the infected target cell and activate a cascade-dependent apoptosis (Dalton et al., 
2004; Zeytun et al., 1997).  
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 Cytotoxic Response against Intracellular Pathogens 
The cytotoxic proteins secreted from CTLs and NK cells contribute to the host defence 
against intracellular pathogens (Kaspar et al., 2001; Smyth et al., 2001). The granule-protein 
mediated response against bacterial infections has been studied on a number of intracellular 
bacteria, and one microorgansim of great interest is Mycobacterium tuberculosis. CTLs and 
NK cells have shown to be protective against M. tuberculosis infections (Gansert et al., 2003; 
Stegelmann et al., 2005; Stenger et al., 1998). The cytotoxic proteins are released from 
cytotoxic granules into the immunological synapse after binding of the antigen specific CTL 
or NK cell to the target cell. The cytotoxic proteins are rapidly secreted from the CTLs and 
NK cells because they are stored in preformed secretory organells, with lysosomal membrane 
proteins and proteolytic enzymes (Burkhardt et al., 1990). These proteins include perforin, 
granzymes and granulysin, which act either alone or in combination with each other 
(Kaufmann, 1999; Pena & Krensky, 1997). The expression of these cytotoxic proteins is 
highly restricted to activated CTLs and NK cells (Peters et al., 1989).  
Regardless of that central effector function of these cytotoxic proteins, the killing mechanism 
and uptake into target cells have not been well investigated, but it is known that binding and 
clustering of perforin and granulysin at the infected target cell membrane leads to uptake and 
finally lysis of the intracellular bacteria (Anderson et al., 2003). 
Perforin 
Perforin is one of the major cytolytic proteins of cytolytic granules of CD8+, γδ, NKT cells 
and CD56+ cells. Shinkai et al. (1988) found that perforin is expressed only in killer cell lines 
and not in helper T cells (Shinkai, Takio & Okumura, 1988). It has been shown that mice 
lacking perforin have lowered protection against intracellular bacteria, which is caused by 
granzyme not being able to enter the cytosol of the target cell without perforin. Within the 
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 group of proteins released from the cytotoxic granules, perforin is the killer cell delivery 
molecule (Kagi et al., 1996). 
Perforin is synthesized as a 70 kDa inactive precursor, which is then cleaved at the C-
terminus to achieve the active 60 kDa form. This processing occurs in the acidic granules of 
the CTLs and NK cells, with a pH of 5.5 (Kataoka et al., 1994). The cleavage of perforin to 
the active form takes place at the boundary of the C2 domain at the C-terminus of perforin. 
This C2 domain is then able to bind to the plasma membrane and to initiate pore-formation, 
due to the conformational change that occurs on the perforin monomer after the cleavage 
(Young et al., 1986). This conformational change takes place in the presence of calcium ions, 
which leads to the binding of perforin to the phosphatidylcholine groups of the membrane 
lipids and to oligomerize to form a pore (Keefe et al., 2005; Tschopp et al., 1989). The 
purpose of perforin was originally thought to be to the insertion into the target membrane for 
pore-formation to allow the uptake of other granule proteins and for them to be delivered to 
the target cell cytosol. But it seems that the formation of these perforin pores are not a 
prerequisite for the uptake of the other granule proteins; granzymes and granulysin (Kurschus 
et al., 2004). 
Calreticulin, which is a calcium storage protein in the cytotoxic granules, colocalizes with 
perforin and both proteins are released together from the cytotoxic granules. Perforin interacts 
with the P-domain of the calreticulin molecule. This domain has a high affinity for binding 
Ca2+. Perforin and calreticulin dissociates after release, when being exposed to higher 
extracellular Ca2+ concentrations. For perforin, calreticulin performs as a Ca2+ regulated 
chaperone, and serves to protect CTLs and NK cell during biogenesis of cytotoxic granules 
(Andrin et al., 1998). The perforin mediated cell death is induced either by uncontrolled 
influx of small molecules such as Ca2+ from the extracellular fluids or by induction of 
osmotic stress resulting in colloid osmotic lysis of the target cell. High concentrations of 
perforin leads to target cell apoptosis (Liu et al., 1995a; Liu et al., 1989). 
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 Granzymes 
Granzymes are proteases belonging to the chymotrypsin superfamily. A large number of 
granzymes have been characterized in human (granzyme A, B, H , K and M) (Kaiserman et 
al., 2006). Granzyme A and granzyme B are most studied granzymes. Granzyme A is a 
specific tryptase, which is stored as an inactive monomer and acts as a 65 kDa homodimer. It 
becomes concentrated in the nucleus of target cells, and together with granzyme B it enhances 
DNA fragmentation. Granzyme A cleaves substrates after basic residues and induces caspase 
independent apoptosis (Trapani et al., 1998).  
The 26 kDa serine proteinase granzyme B can in addition of induction of apoptosis by 
activation of caspases, also directly cleave cytoplasmic substrates such as the thrombin 
receptor and the actin-binding protein filamin (Browne et al., 2000). Granzyme B is crucial 
for the rapid induction of target cell apoptosis by CTLs. Perforin can greatly enhance the 
uptake of granzyme B (Jans et al., 1996; Shi et al., 2005), but this protein can also enter 
infected cells in a perforin-independent manner (Froelich et al., 1996). Even though 
granzymes are endocytosed in a perforin independent manner, perforin is needed for the 
intracellular delivery of granzymes. It is known that granzyme B alone is not effective in the 
target cell killing, but in combination with perforin, granzyme B is able to induce apoptosis of 
the target cell (Giesubel et al., 2006; Kurschus et al., 2004).  
After entering the target cells, granzymes promote DNA degradation by cleaving histones, 
which leads to an easier access of deoxyribonucleases to the nucleus. However, it has been 
shown that granzymes are also indirectly involved in DNA degradation by either binding to 
nuclear proteins such as nucleolin, and then subsequently cleaving DNA (Smyth & Trapani, 
1995). The entering of granzyme B into the cell in a perforin independent manner predicts the 
existence of a cell surface receptor for granzyme B. Motyka et al. (2000) presented 
verification that this receptor is the cation-independent mannose 6-phosphate receptor called 
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 IGF2R. Inhibition of the interaction between granzyme B and the IGF2R receptor prevents 
granzyme B from binding to the cell surface, which subsequently prevents uptake, and the 
induction of apoptosis. Significantly, expression of the IGF2R receptor is necessary for CTL-
mediated apoptosis of target cells in vitro (Motyka et al., 2000; Patel, Gores & Kaufmann, 
1996). Granzyme also enters the cell by binding to the cell surface due to the positive charges 
on the protein. It has been shown that the binding of granzyme B is mainly dependent on the 
charges (Shi et al., 2005).  
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 THE ANTIMICROBIAL PROTEIN GRANULYSIN 
Granulysin was first mentioned by Jongstra el al. (1987), who found a gene encoding for the 
protein 519, which is expressed late after T cell activation. Pena et al. (1997) described 519 as 
a lytic molecules stored in and released from the cytotoxic granules of CTLs and NK cells 
called granulysin (Jongstra et al., 1987; Pena et al., 1997).  
The antimicrobial protein granulysin is active against a broad range of pathogens, such as 
Listeria monocytogenes, Mycobacterium tuberculosis and Trypanosoma cruzi (Clayberger & 
Krensky, 2003; Krensky, 2000; Stenger et al., 1998). One detectable effect of the action of 
granulysin against M. tuberculosis is the development of protruding lesions on the target cell 
surface (Stenger et al., 1998), which increases the permeability of the membranes resulting in 
osmotic lysis. Together with perforin, granulysin is able to enter the infected host cell and to 
kill intracellular bacteria without simultaneous apoptosis. Though, the structure of granulysin 
suggests that it could be able to bind to and perturb membranes also in a perforin-independent 
manner (Anderson et al., 2003; Thoma-Uszynski, Stenger & Modlin, 2000).  
Processing, Regulation and Activation of Granulysin 
The gene of granulysin is located on the human chromosome 2 (Donlon, Krensky & 
Clayberger, 1990) and includes six exons within a 3,9 kb genomic locus encoding at least four 
alternative spliced transcripts (NKG5, 519, 520 and 522), all differing mainly in exon 2. The 
most abundant transcript in the functional human CTL cell line AJY was 520 appearing late 
after T cell activation (Manning et al., 1992). Since the transcript 520 has a fitting Kozak 
sequence for the beginning of translation, this transcript was thought to be responsible for the 
large amount of granulysin produced (Pena & Krensky, 1997). NKG5, a similar transcript to 
520, was not found in the AJY, but would have the same purpose in NK cells (Houchins et al., 
15
 1993). We also found in primary cultured cells the transcripts for NKG5, two variants of 519 
and two novel short forms of granulysin (Latinovic-Golic et al., 2007).  
Granulysin is expressed as a 15 kDa protein and then processed by proteolytic cleavage at 
both N and C termini of the 15 kDa precursor to the active 9 kDa form (Hanson et al., 1999). 
The 15 kDa form of granulysin is rapidly produced, but has a shorter half-life and is poorly 
secreted, whereas the secretory 9 kDa form is produced slowly and is relatively stable (Pena 
& Krensky, 1997). 
Structure of Granulysin and Related Proteins 
Granulysin belongs to the saposin-like protein (SAPLIP) family, which includes amoebapores 
(Bruhn & Leippe, 1999), NK-lysin (Liepinsh et al., 1997) and saposin A, B, C and D 
(Clayberger & Krensky, 2003; Krensky, 2000; Morimoto et al., 1988; Morimoto et al., 1989; 
O'Brien & Kishimoto, 1991; Qi & Grabowski, 2001). The family members are cationic 
membrane interacting proteins and they share a particular polypeptide motive of a five-helical 
bundle and highly conserved cysteine residues that form disulphide bonds (Munford, 
Sheppard & O'Hara, 1995), which give the molecule a stable structure. They interact with a 
variety of lipids, especially negatively charged phospholipids, cholesterol and sphingolipids 
(Vaccaro et al., 1995; Vaccaro et al., 1999). Although the SAPLIP family members have 
structural similarities, they have various biological functions: amoebapores are capable of 
forming ion channels or pores in lipid membranes (Lynch, Rosenberg & Gitler, 1982; Young 
et al., 1982), saposin A - D modify the membrane to become substrates for enzymes, whereas 
granulysin and NK-lysin appear to directly permeabilize bacterial membranes (Anderson et 
al., 2003; Krensky, 2000).  
Comparing the amino acid sequences of the SAPLIP family members reveals that granulysin 
has the highest identity to NK-lysin (43% identity), a porcine protein with antibacterial 
activity (Andersson et al., 1995). The structural comparision of NK-lysin and saposin C with 
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 granulysin can be seen in Figure 1. NK-lysin is a 9 kDa cationic protein produced in cytolytic 
lymphocytes (Andersson et al., 1996; Andersson et al., 1995; Andreu et al., 1999; Stenger et 
al., 1998). It is expressed in CD2+, CD4+ and CD8+ cells, which suggests that it functions as 
an effector protein of CTLs and NK cells. The structure consists of five amphipathic α-helices 
folding into a single globular domain with a hydrophobic core and a hydrophilic surface 
(Andersson et al., 1995). The charge distribution in NK-lysin implies a specific orientation for 
its primary contact to a negatively charged lipid bilayer, but similar to granulysin, the 
structure of NK-lysin does not suggest an obvious mechanism for pore formation (Liepinsh et 
al., 1997). It lyses membranes by molecular electroporation by burying one tryptophan 
residue (Trp58) in the bacterial membrane without changing its secondary structure, which 
results in pore formation or defects in the bacterial membrane (Miteva et al., 1999).  
Saposin A, B, C and D are derived from the proteolytic processing of the precursor protein 
called prosaposin, and processed into four individual saposins and they also share the 
particular polypeptide motive of five α-helices and highly conserved cysteine residues known 
for the SAPLIP family members (Kolter & Sandhoff, 2005). Each individual saposin activates 
the breakdown of specific lipid substrates by assisting the access of the lipid headgroups to 
the active sites of cognate hydrolases. In the absence of these sphingolipid activators, the 
oligosaccharide chains of the membranelipids cannot reach far enough into the lysosomal 
lumen to be accessible to the active sites of the hydrolases. All saposins are able to activate 
lipid hydrolysis by solubilizing the lipid substrates or by destabilizing the membrane structure 
(Salvioli et al., 2000). Saposin C, which has the highest homology of all the saposins to 
granulysin, plays an important role in the activation of glucosylceramidase, the enzyme that 
degrades glucosylceramide and glucose in lysosomes (O'Brien & Kishimoto, 1991; Qi & 
Grabowski, 2001; Vaccaro et al., 1999). 
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Figure 1. From left: schematic drawings of the three-dimensional structures of granulysin, 
NK-lysin and saposin C showing the charge distribution, the disulphide bonds and the helices. 
All these proteins are able to associate and modulate membranes, and they belong to SAPLIP 
family of lipid binding proteins. 
Binding of Granulysin to Membranes 
Granulysin is a highly positively charged molecule, which allows it to bind to the negatively 
charged bacterial membrane, but the structure of granulysin does not predict a pore-formation, 
suggesting another mechanism of action for perturbing the eukaryotic membrane and to lyse 
the intracellular prokaryotic membranes (Anderson et al., 2003). Granulysin, like to other 
members of the SAPLIP family, binds to the negatively charged bacterial or cell membrane. 
The crystal structure revealed by Anderson et al. (2003) suggests that the initial contact 
between granulysin and the membrane is mediated by the positive charged from the arginine 
residues attracted to negative charges in the membrane phosphates. Positive charges not 
involved in first contact with the membrane would maintain force to drive granulysin into the 
membrane surface, and could drive subsequent events, such as lysis of intracellular bacteria 
(Anderson et al., 2003).  
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 Prokaryotic and Eukaryotic Membranes 
One of the goals in this study was to find if granulysin is able to distinguish between 
prokaryotic and eukaryotic cells, which differ in the lipid composition of their membranes, 
and how granulysin may reach its intracellular target. An eukaryotic cell membrane consists 
of cholesterol, sphingomyelin and phospholipids, such as phosphatidylcholine (PC), 
phosphatidylethanolamine (PE), phosphatidylserine (PS) and phosphatidylglycerol (PG), 
whereas the membrane of a prokaryotic cell lacks cholesterol and sphingomyelin, consisting 
mainly of cardiolipin, PC, PE, PS and PG, from which cardiolipin, PC, PE and PG are found 
in both membrane leaflets, whereas phosphatidylserine is mainly located in the cytoplasmic 
leaflet (Gidalevitz et al., 2003; Kurz et al., 2005; Pomorski et al., 2004; Tannert et al., 2003). 
Eukaryotic cells are able to take up extracellular material, which are too large to be taken up 
via membrane pores, through the endocytosis pathway. These pathways are also utilized by 
bacteria and viruses. One endocytic mechanism is the receptor-mediated endocytosis via 
clathrin-coated pits (Husain & Moss, 2005; Orci et al., 1989). Another entry route into 
eukaryotic cells is through parts of the membrane driven by a coat made of caveolin, named 
caveolae (Nunes-Correia et al., 2004; Rothberg et al., 1992).  
Additionally to clathrin-coated pits and caveolae, lipid rafts are also important mediators for 
endocytosis (Brown & London, 2000; Cambi et al., 2004; Manes, del Real & Martinez, 2003). 
They are specialized cholesterol-enriched microdomain in the eukaryotic membrane. Since 
1972, it has been believed that, in cell membranes, phospholipids and membrane proteins are 
distributed all over according to a fluid mosaic model (Helms & Zurzolo, 2004; Singer & 
Nicolson, 1972; Somerharju, Virtanen & Cheng, 1999). However, in 1988, Kai Simons and 
Gerrit van Meer suggested the new idea that there exist microdomains enriched with 
cholesterol and sphingolipids, which are present in cell membranes (Simons & van Meer, 
1988). This was the first time these microdomains were called lipid rafts. The original idea of 
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 rafts was used as an explanation for the transport of cholesterol from the trans-Golgi to the 
plasma membrane (Simons & Ikonen, 1997). 
Cholesterol has an important role in lipid rafts, but also in lipid bilayers, which usually exist 
in an ordered gel phase under the transition temperature of their lipids. However, cholesterol 
is able to eradicate the sharp transition between ordered gel phase and liquid crystalline phase, 
resulting in a liquid ordered phase, where the lipids have a high degree of lateral mobility as 
well as tightly packed acyl chains, illustrated in figure 2 (Brown & London, 2000; McMullen 
& McElhaney, 1997; Pralle et al., 2000; Simons & Ikonen, 1997). The difference in the 
eukaryotic and prokaryotic membranes, such as the lack of cholesterol in prokaryotic 
membranes, may be of importance for the mechanism of action of granulysin. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Lipid organization in membranes and lipid rafts. A schematic drawing based on the 
theoretical shape of phospholipids (PL), sphingomyelin (SM) and cholesterol showing the 
tighter packing of the cholesterol enriched microdomains. 
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 OLIGOMERIZATION OF GRANULYSIN 
Other cytotoxic proteins, such as streptolysin O, anthrolysin O and perfringolysin O, have 
been shown to form oligomers to be able to be active (Cocklin et al., 2006; Ramachandran, 
Tweten & Johnson, 2004; Ramachandran, Tweten & Johnson, 2005; Walev et al., 1995). 
These toxins first bind in a monomer form to lipid bilayers, then the molecules collide with 
one another, leading to a formation of non-covalently bonded polymeric aggregates (Alving et 
al., 1979; Cocklin et al., 2006; Johnson, Geoffroy & Alouf, 1980; Walev et al., 1995).  
Also pores formed by perforin molecules grow in diameter through the progressive 
recruitment of additional monomers. Within these resulting oligomers of perforin molecules, 
the hydrophobic amino acid residues of the monomers face the acyl chains of the membrane 
lipids, whereas the hydrophobic residues are thought to line the interior of the oligomer. This 
barrel stave model also offers a molecular basis for the heterogeneity in size observed for 
perforin pores, which internal diameters ranges from 5 to 20 nm (Young & Cohn, 1986).  
At this day, not much is known about the oligomerization of granulysin. It is known that the 
first contact is mediated by the positive changes of the arginine residues, but since the 
structure of the protein does not predict a pore formation, similarly to other SAPLIP family 
members (Anderson et al., 2003), and the size of the protein is too small to be able to 
independently cause lesions, the membrane permeabilization of bacterial membranes after 
binding of granulysin is thought to originate from oligomerization of the protein. The lesions 
shown by Stenger et al. (1998) on the membranes of M. tuberculosis are much larger than 
individual granulysin molecules, supporting the theory of oligomerization. Several granulysin 
molecules may participate in each membrane defect (Stenger et al., 1998). Anderson et al. 
propose a model for the mechanism of action for granulysin, where each granulysin molecule 
binds to its neighbouring molecules, applying local forces to a part of the membrane. This 
tight packing of the granulysin molecules could allow a cooperative bacterial membrane lysis 
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 by a friction between the neighbouring molecules (Anderson et al., 2003). This model 
correlates with the carpet model, where protein molecules covers the infected cell by first 
binding to the membrane using electrostatic interactions and, second, permeabilization of the 
membrane is induced only where the protein concentration is high enough (Anderson et al., 
2003; Pouny et al., 1992; Shai, 1999). However, an experimental basis has been missing for 
the mechanism of granulysin, that allows concise conclusions about the pore or defect 
formation of granulysin on eukaryotic and prokaryotic membranes. 
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 AIMS OF THE STUDY 
The central focus of this study was to investigate how the cytotoxic protein granulysin 
interacts with eukaryotic and prokaryotic membranes, as well as the mechanism how it enters 
the infected target cell to kill intracellular bacteria. 
Aim 1: 
The first aim was to show how granulysin is taken up by Listeria innocua infected host cells. 
Aim 2: 
The second aim was to find out how granulysin interacts with prokaryotic and eukaryotic 
membranes, as well as if the binding and permeabilization of eukaryotic membranes is 
different to prokaryotic membranes. 
Aim 3: 
The third aim was to find out the reason behind the possible difference in the interaction 
between granulysin and prokaryotic versus eukaryotic membranes and to study and visualize 
the binding and permeabilization of membranes with different charges and lipid components. 
Aim 4: 
The fourth aim was to investigate how granulysin is able to permeabilize membranes as well 
as the reason why eukaryotic cells are not lysed by granulysin.  
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 RESULTS 
Paper 1: Uptake of Granulysin via Lipid Rafts leads to Lysis of 
Intracellular Listeria innocua 
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Uptake of Granulysin via Lipid Rafts Leads to Lysis of
Intracellular Listeria innocua
Michael Walch, Elisabeth Eppler, Claudia Dumrese, Hanna Barman, Peter Groscurth, and
Urs Ziegler1
The bacteriolytic activity of CTL is mediated by granulysin, which has been reported to kill intracellular Mycobacterium tuber-
culosis in dendritic cells (DC) with high efficiency. Despite that crucial effector function, the killing mechanism and uptake of
granulysin into target cells have not been well investigated. To this end we analyzed granulysin binding, uptake, and the subse-
quent lysis of intracellular Listeria innocua in human DC. Recombinant granulysin was found to be actively taken up by DC into
early endosomal Ag 1-labeled endosomes, as detected by immunofluorescence. Further transfer to L. innocua-containing phago-
somes was indicated by colocalization of bacterial DNA with granulysin. After uptake of granulysin by DC, lysis of L. innocua was
found in a dose-dependent manner. Uptake as well as lysis of Listeria were inhibited after blocking endocytosis by lowering the
temperature and by cholesterol depletion of DC. Colocalization of granulysin with cholera toxin during uptake showed binding
to and internalization via lipid rafts. In contrast to cholera toxin, which was targeted to the perinuclear compartment, granulysin
was found exclusively in endosomal-phagosomal vesicles. Lipid raft microdomains, enriched in the immunological synapse, may
thus enhance uptake and transfer of granulysin into bacterial infected host cells. The Journal of Immunology, 2005, 174:
4220–4227.
C ytotoxic T lymphocytes and NK cells play an essentialrole in the host defense against intracellular pathogenssuch as Chlamydia, Listeria, and Mycobacteria (1). The
mechanisms of CTL and NK cells involved in clearance of intra-
cellular bacteria are release of cytokines (2), especially of IFN-
and TNF-, induction of target cell apoptosis (3), and direct me-
diation of antibacterial activity (4). The bacteriolytic activity of
CTL is mediated by granulysin, a 9-kDa protein stored in cytolytic
granules together with perforin and granzyme B (5). It was dis-
covered by a subtractive hybridization procedure of late activated
T cells (6, 7) and exhibited a vast spectrum of antimicrobial ac-
tivity against bacteria, fungi, and parasites (8), either as free mi-
croorganisms or located in host cells. The killing of intracellular
Mycobacterium tuberculosis by V9/V2 T lymphocytes was
shown to be dependent on granulysin (9). Furthermore, it was re-
ported that V9/V2 T cells from children with tuberculosis have
strongly reduced effector functions, indicated by decreased IFN-
production and granulysin expression, which was recovered upon
chemotherapy (10). Other groups found granulysin responsible for
the antimycobacterial activity of NKT cells (11) or CTL (8). Com-
parable results were obtained when investigating Mycobacterium
leprae, which also survives within phagosomes of host cells (12,
13). Ochoa et al. (12) showed, by phenotyping of cells in dermal
granulomas of leprosy lesions, that there are masses of granulysin-
containing cells. These cells were identified as CD4 T cells.
Moreover, the frequency of T cells containing granulysin in lesions
reflected the capacity of the patients to restrict the disease. A recent
study revealed granulysin-containing CD4 T cells infiltrating af-
fected follicles and perilesional dermis in superficial microbial fol-
liculitis (13). Together, these results indicate that there is little
doubt that granulysin is crucial for the mediation of antibacterial
activity of CTL and NK cells.
Granulysin belongs to the saposin-like protein family (SAP-
LIP).2 These proteins share a particular polypeptide motive and
affinity to a variety of lipids, especially sphingolipids (14), as well
as to cholesterol (15). The interaction of saposins with sphingo-
lipids has been extensively investigated. Dependent on the pH
value, all saposins were reported to bind negatively charged gan-
gliosides (16, 17). Positive charges at neutral pH are crucial for
lytic activity of granulysin against bacteria and negatively charged
liposomes (18). After binding and clustering of granulysin at the
bacterial membrane, deformation of the membrane might lead to
bacteriolysis (19).
Although the lytic activity of granulysin against a wide spec-
trum of microorganisms has been well studied (8, 20, 21), few data
are available about the interaction of granulysin with the host cell
itself, in particular on binding, uptake, and intracellular trafficking.
Binding of granulysin may be mediated by lipid rafts, which are
specialized membrane microdomains composed of sphingolipids
and cholesterol in the outer exoplasmic leaflet as well as phospho-
lipids and cholesterol in the inner cytoplasmic leaflet (22). There is
abundant evidence that rafts are involved in a variety of cellular
functions, including endocytosis of pathogens (23–25) and bacte-
rial endotoxins (26, 27), as well as in protein sorting and ligand-
induced signal transduction (28).
With respect to granulysin uptake in infected host cells, it is
under debate whether other lytic proteins secreted by CTL and NK
cells, such as perforin, assist in internalization of granulysin in
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infected host cells. Recombinant granulysin killed intracellular lo-
cated M. tuberculosis only if cells were incubated simultaneously
with perforin (8). In contrast, the killing of intracellular M. tuber-
culosis by CD4 T cells and CD8 CTLs was independent of
perforin (29). CD4 T cells that occurred in leprosy lesions were
negative for perforin (12). Furthermore, it is known from studies
with perforin knockout mice that perforin is not required for the
early control of mycobacterial infection in mice (30). Perforin-
independent granulysin uptake has also been shown to some extent
in Jurkat cells, where homogeneous distribution of granulysin in
the cytoplasm of cells was found after incubation with high con-
centrations of up to 50 M granulysin (31).
In our study we analyzed binding, uptake, and intracellular traf-
ficking of granulysin using human monocyte-derived dendritic
cells (DC) as hosts harboring Listeria innocua. DC are profes-
sional APCs that are crucial for the induction of a cellular immune
response. They possess several mechanisms to internalize macro-
molecules and pathogens for Ag processing and presentation to T
cells (32). The mechanisms involved in uptake are receptor-medi-
ated endocytosis via clathrin-coated pits, phagocytosis, macropi-
nocytosis, and lipid rafts (25, 33). L. innocua is a Gram-positive,
apathogenic bacterium ubiquitously distributed in our environment
(34). Upon phagocytosis, it is transferred via endosomes to phago-
somes, where it resides until transfer to and lysis in phagolyso-
somes (35). Uptake and trafficking of granulysin were correlated to
established markers of the endocytic pathway as well as to cholera
toxin to evaluate whether lipid rafts are involved in a perforin-
independent mechanism of granulysin uptake and killing of intra-
cellular L. innocua.
Materials and Methods
Production of recombinant granulysin and anti-granulysin Abs
Due to the postulated C-terminal posttranslational processing of native
granulysin in CTLs (5), two recombinant granulysins of different lengths
were cloned from cDNA that was reverse transcribed from total RNA
extracted from human lymphokine-activated killer cells. Both constructs
corresponding to NKG5 started with G 63 and ended with D 132, or L 145,
respectively, for granulysin132 or granulysin145. A fragment of human
-actin identical in length with granulysin132 was additionally reverse tran-
scribed for use as a control protein, referred to as actinfrag. These inserts
were cloned in pEt28a (Novagen), followed by a factor Xa cleavage site
(IEGR/G) and a C-terminal hexahistidine tag (His-tag). Proteins were ex-
pressed in Escherichia coli BL21 (DE3) additionally transformed with the
chloramphenicol-resistant plasmid, pRARE (Novagen) in Luria-Bertoni
medium containing 50 g/ml kanamycin, 34 g/ml chloramphenicol, and
2% glucose (all from Sigma-Aldrich). Expression was induced with 1 mM
isopropyl--D-thiogalactoside (Qbiogene). After lysis of bacteria by adding
1 mg/ml lysozyme, 1% Triton X-100, 50 g/ml DNase, and 5 g/ml
RNase (all from Sigma-Aldrich), granulysin was purified via nickel affinity
chromatography and further renatured according the protocol of Ernst et al.
(20). Renatured recombinant granulysin was additionally purified using
Sep-Pak Vac 6cc (1 g) C18 cartridges (Waters) and was eluted with 100%
acetonitrile containing 0.1% trifluoroacetic acid. After lyophilization, the
protein concentration was determined using the Bio-Rad protein assay.
Protein purity was estimated by SDS-PAGE and N-terminal sequencing
(University of Zurich), revealing the correct first four amino acids
as GRDY.
For Ab production and cleavage of the C-terminal His-tag, the dialysate
containing granulysin145 was concentrated by lyophilization, and after re-
hydration, it was treated with factor Xa (Amersham Biosciences) for 2 h at
4°C to remove the His-tag. The efficiency of His-tag removal was assessed
by Western blotting and was routinely 99%. After His-Tag cleavage,
granulysin145 was reverse phase purified as described above. Polyclonal
anti-granulysin Abs were raised in guinea pig (Pineda).
Viability determination of L. innocua
Serial dilutions of L. innocua-loaded cells lysed by adding ice-cold water
or suspension-treated L. innocua were spread on tryptic soy broth (TSB;
Difco) agar plates. CFU were determined by counting colonies after over-
night culture at 37°C, and specific lysis was calculated using the formula
((CFUs in buffer control  CFUs in test incubation)/CFUs in buffer
control)  100.
Alternatively, turbidimetry was used to study specific lysis of bacteria
(36). Serial dilutions of cell lysates or treated L. innocua were incubated in
96-well plates (Nunc). Bacterial growth curves were monitored in a mi-
croplate reader (Spectra MAX 340; Molecular Devices) at OD600 with
discontinuous shaking for 16 h at 37°C. Specific lysis was calculated by
determining the time when the maximum population was reached in buffer
controls (ODTmax-control). At this point, the OD value (ODTmax-Test) of a
shifted growth curve was evaluated, and specific lysis was calculated
using the formula ((ODTmax-control  ODmin)  (ODTmax-test  ODmin)/
ODTmax-control  ODmin)  100. All OD values were corrected by sub-
traction of the baseline OD (ODmin).
Bacteriolytic activity of granulysin
Granulysin was incubated at various concentrations for 3 h at 4 or 37°C
with 105/ml L. innocua in 0.01 M Trisma base (pH 8). Actinfrag and buffer
alone served as controls. After incubation, the viability of L. innocua was
determined as described above. For some experiments, granulysin132 was
pretreated with 2,3-butanedione (BAD) or with citraconic anhydride
(CAH; both from Sigma-Aldrich) in 10 mM sodium borate buffer for 2 h
at room temperature. During incubation, the pH was controlled and ad-
justed between 8 and 9. Granulysin132 incubated in borate buffer alone
served as a control. Binding of BAD and CAH to granulysin was analyzed
using electrospray mass spectrometry (University of Zurich; not shown).
To study binding of granulysin to L. innocua, 106/ml bacteria were
incubated with granulysin or actinfrag in a concentration of 2.5 M for 15
min at 37 or 4°C, respectively. Bacteria were washed subsequently three
times with ice-cold PBS and fixed with 1.5% paraformaldehyde in PBS
containing 1% sucrose.
Isolation and culture of DC
Human DC were generated in vitro from blood-derived precursors as pre-
viously described (37). Briefly, human PBMC obtained from venous blood
of healthy donors (Blood Bank SRK) were isolated by Ficoll-Paque (Phar-
macia Biotech) density centrifugation. The PBMC were cultured in RPMI
1640 supplemented with penicillin/streptomycin (all from Invitrogen Life
Technologies) and 10% heat-inactivated pooled human A serum (Blood
Bank SRK) for 2 h. The adherent cells were cultured for 6 days in RPMI
1640 supplemented with penicillin/streptomycin, 5% heat-inactivated
pooled human A serum (DC culture medium) with rhGM-CSF (50 ng/ml;
Novartis), and human rIL-4 (100 U/ml; R&D Systems).
Challenge of DC with Listeria
L. innocua were propagated in TSB at 37°C overnight, diluted 10-fold, and
further expanded to an OD600 of 0.5 corresponding to 5  107/ml viable
bacteria. Bacteria were harvested by centrifugation and washed twice with
PBS before opsonization in RPMI 1640 with 50% pooled heat-inactivated
human A serum for 30 min at 37°C. Opsonized Listeria were washed in
PBS and resuspended in RPMI 1640. DC were challenged for 1 h with a
multiplicity of infection of 5. Subsequently, cultures were washed with
PBS and incubated for 3 h in DC culture medium containing 25 g/ml
gentamicin (Sigma-Aldrich) to kill extracellular L. innocua. Cholesterol
depletion of DC was achieved by addition of -methyl-cyclodextrin
(MCD; Sigma-Aldrich) in RPMI 1640 without human serum for 1 h
at 37°C.
Granulysin treatment of DC
L. innocua-challenged or unchallenged DC were incubated with various
concentrations of granulysin, actinfrag, or culture medium alone for the
indicated times at 37 or at 4°C, subsequently washed twice with PBS, and
either fixed with 1.5% paraformaldehyde in PBS containing 1% sucrose for
immunofluorescence labeling or lysed by adding ice-cold sterile water for
30 min on ice for assessment of viability of L. innocua as described above.
DC were also incubated with granulysin132 that was pretreated with BAD
or CAH at the indicated concentrations in 10 mM sodium borate buffer or
sodium borate buffer alone as a control. After incubation with modified
granulysin for 1 h at 4°C, the cells were washed twice with ice-cold PBS
and lysed with PBS containing 0.5% Triton. The content of granulysin
bound to DC membranes was determined by Western blot analysis. Sam-
ples were run on a 15% SDS-PAGE gel and blotted on transfer membranes
(Immobilon-P; Millipore). Granulysin was detected using anti-granulysin
Ab. As a reference, cellular actin was detected using an anti-actin mAb
(AC15; Sigma-Aldrich). The granulysin content bound to DC was mea-
sured and calculated relative to cellular actin using Image-J software (Na-
tional Institutes of Health).
4221The Journal of Immunology
26
Confocal laser scanning microscopy (CLSM)
Fixed DC were cytospun onto glass slides and permeabilized with 0.1%
Triton X-100 (Sigma-Aldrich) in PBS for 1 min at room temperature. Un-
specific binding was blocked with 0.1% BSA (Fluka) in PBS for 1 h room
temperature. Recombinant His-tagged granulysin132, granulysin145 after
His-tag removal, or His-tagged actinfrag were detected with an anti-His
mAb (1/1,000; Invitrogen Life Technologies) or with guinea pig anti-
granulysin antiserum (1/10,000). Lysosomes were labeled with a lysoso-
mal-associated membrane protein 1 (LAMP-1) mAb (1/50), early endo-
somes were labeled with a rabbit early endosomal Ag 1 (EEA-1) Ab (1/
200; Affinity BioReagents), and CD55 was labeled with an anti-CD55 mAb
(Accurate Chemical). Omitting the first Abs served as a control for spec-
ificity. For detection, the following Abs were used: FITC-conjugated goat
anti-mouse or a goat anti-rabbit Ab, Cy3-labeled goat anti-guinea pig Ab
(all from Kirkegaard & Perry Laboratories), or Texas Red-conjugated don-
key anti-mouse Ab (Jackson ImmunoResearch Laboratories). All Abs were
diluted in 0.1% BSA in PBS. DNA was labeled with 1 g/ml 4,6-diami-
dine-2-phenyl-indol-dihydrochloride (DAPI; Roche) in PBS for 15 min at
room temperature.
For co-uptake experiments L. innocua-challenged DC were simulta-
neously treated with granulysin or actinfrag in combination with cholera
toxin-FITC (10 g/ml; Molecular Probes), dextran-FITC (1 mg/ml;
m.w. 40,000; Sigma-Aldrich), or transferrin-FITC (25 g/ml; Molecular
Probes) for various time periods. Alternatively, L. innocua-challenged DC
were pulsed with granulysin and cholera toxin-FITC for 10 min on ice.
Subsequently, cells were washed twice with ice-cold PBS and transferred
to 37°C for the indicated chase periods before fixation and processing as
described above.
Fluorescent-labeled specimens were examined using a confocal laser
scanning microscope (CLSM SP1; Leica). Images were analyzed using the
Imaris software package (Bitplane), and threshold levels for calculation of
colocalization micrographs were selected above background signals. Im-
ages representing single sections through three-dimensional volume stacks
are shown.
Results
Bacteriolytic activity of recombinant granulysin
The antibacterial activity of granulysin132 and granulysin145, re-
spectively, was monitored by assessing the viability of L. innocua
in suspension. His-tagged granulysin132-treated L. innocua were
found to have a lowered viability depending on the granulysin132
concentration used for incubation (Fig. 1A). This activity was iden-
tical with the antibacterial activity of granulysin145 without a C-
terminal His-tag. At a concentration of 2.5 M, 90% of the
bacteria were killed. Significant bacteriolysis could still be mea-
sured at a concentration of 0.15 M. Actinfrag, a His-tagged frag-
ment of human -actin, identical in length, expression, and puri-
fication, used as a control to granulysin, did not affect L. innocua
viability.
To investigate the kinetics of granulysin-induced bacteriolysis,
L. innocua in suspension were incubated with 2.5 M granuly-
sin132 or granulysin145 without His-tag, and lysis was stopped by
adding TSB at the indicated time points. Growth inhibition by
granulysin was monitored and calculated from Listeria growth
curves. The onset of bacteriolysis occurred very rapidly, with
70% of the bacteria killed after 5 min of granulysin treatment at
37°C (Fig. 1B). Fifteen minutes of granulysin incubation at 37°C
was sufficient to kill 90% of the bacteria. Lowering the tempera-
ture to 4°C during incubation decreased specific bacteriolysis to
55% after 15 min and to 70% after 45 min, but did not abolish lysis
(Fig. 1B).
After incubation with 2.5 M granulysin132 for 15 min and
staining with an anti-His mAb, L. innocua were coated by granu-
lysin132 (Fig. 1C). Granulysin132 bound to bacteria was also de-
tected after treatment at 4°C (data not shown). No binding of ac-
tinfrag was detected after treating the Listeria with actinfrag (Fig.
1D). According to these findings, granulysin binds and kills L.
innocua highly efficiently within minutes at 37 or 4°C.
Granulysin is actively taken up by DC
To lyse intracellular bacteria, granulysin has to enter the cell either
by a passive or an active uptake mechanism. Active protein uptake
is a temperature-dependent process; therefore, granulysin uptake
was investigated at 37 and 4°C. For this purpose, DC were treated
for 45 min at 37°C with granulysin132 or actinfrag, and the local-
ization of the proteins was determined by immunofluorescent
staining using an anti-His mAb. CLSM revealed a spot-like pattern
of immunolabeled granulysin132 within the DC (Fig. 2A). Granu-
lysin132 distribution was identical in L. innocua-challenged DC
(data not shown). After incubation for 45 min at 4°C, granulysin132
was found exclusively at the cell membrane, and no significant
transfer to an intracellular compartment occurred (Fig. 2B), indi-
cating an active uptake mechanism. Actinfrag was neither bound
nor taken up by DC at detectable levels (Fig. 2C).
Ernst et al. (20) demonstrated that modification of arginine res-
idues with BAD reduced the binding as well as the lytic capacity
of granulysin against E. coli, whereas neither binding nor lytic
capacity of granulysin pretreated with CAH to modify lysine res-
idues was affected. Consistent with these results, pretreatment of
granulysin132 with BAD reduced the lytic activity against L. in-
nocua in suspension, whereas CAH or borate buffer alone had no
FIGURE 1. Bacteriolytic activity of recombinant granulysin against L.
innocua in suspension. A, L. innocua were incubated for 3 h at 37°C with
granulysin132, granulysin145, or actinfrag as a control in various concentra-
tions. Specific lysis was determined in CFU assays. The mean  SE of
three independent experiments are presented. B, L. innocua were treated
with 2.5 M granulysin145, granulysin132, or actinfrag for various time pe-
riods at 37 and 4°C. Specific lysis was calculated from bacterial growth
curves obtained by turbidimetry. The mean  SE of three independent
experiments are presented (Œ, granulysin132, 37°C; , granulysin145,
37°C; F, actin132, 37°C; ‚, granulysin132, 4°C; , granulysin145, 4°C).
Granulysin132-treated (C) or actinfrag-treated (D) L. innocua were stained with
an anti-His mAb for CLSM. Representative phase contrast (left panels) and
immunofluorescence images (right panels) are shown. Bar  4 m.
4222 GRANULYSIN MEDIATION OF BACTERIOLYTIC ACTIVITY OF CTL
27
effect (Fig. 2E). Preincubation of granulysin with BAD, but not
with CAH, significantly decreased binding of granulysin132 to DC
cell membranes, as assessed by Western blotting (Fig. 2D). Similar
to binding, uptake of granulysin132 at 37°C was not affected by
modification of lysine residues (not shown).
Granulysin binding and uptake in DC are associated with
lipid rafts
The spot-like staining pattern of granulysin132 within DC resem-
bled vesicles of the endocytic pathway. Because granulysin be-
longs to the SAPLIP, which has known affinity to sphingolipids
(5), a binding and initial uptake mechanism associated with lipid
rafts seemed likely. Lipid rafts are highly organized microdomains
in the plasma membrane with elevated cholesterol and glycosphin-
golipid contents (22). The  subunit of cholera toxin binds the Gm1
ganglioside in lipid rafts and is a well-established marker to detect
such microdomains (38). To examine possible association of
granulysin binding and uptake in DC via lipid rafts, co-uptake
experiments with fluorescently labeled cholera toxin and granuly-
sin were performed. After incubation of granulysin132 with cholera
toxin for 30 min in steady state at 37°C, both proteins were found
colocalized in DC (Fig. 3A, see colocalization panel). The colo-
calization of cholera toxin and granulysin132 was most significant
in the peripheral part of the cells. Cholera toxin was concentrated
over time in the perinuclear area of the DC, whereas granulysin132
remained in the peripheral compartment. No uptake of the proteins
occurred at 4°C (Fig. 3B). Under these conditions granulysin132
and cholera toxin were colocalized and remained in a patch-like
pattern at the cell membrane. To exclude an interaction of the
His-tag of granulysin132 with the cell membrane, especially with
lipid rafts, DC were coincubated with granulysin145 after His-tag
removal and cholera toxin at 37 and 4°C (Fig. 3, C and D). After
fixation, the samples were stained with the anti-granulysin Ab. We
found a staining pattern identical with that achieved with granu-
lysin132, proving that the His-tag did not influence granulysin bind-
ing or uptake in DC. The assumption of initial co-uptake and later
separation of granulysin132 and cholera toxin was confirmed in
pulse-chase experiments. Granulysin132 and cholera toxin were al-
lowed to bind to DC on ice for 10 min, and subsequent to medium
replacement, cells were incubated at 37°C for 5–90 min (Fig. 3E).
After 5 min, both proteins were colocalized, either still bound to
the cell membrane or in the peripheral compartments of the cells.
Thirty minutes after binding to the cell membrane, granulysin132
and cholera toxin had separated into different compartments. After
90 min, cholera toxin was found highly concentrated near the nu-
cleus and was totally separated from granulysin132, which re-
mained in the peripheral compartment of the cells (see colocaliza-
tion panels in Fig. 3F). The association of granulysin with lipid
rafts in DC was confirmed by staining of granulysin132-treated DC
with an anti-CD55 Ab and an anti-granulysin Ab (Fig. 3G). To test
possible involvement of macropinocytosis or clathrin-dependent
endocytosis in granulysin132 uptake, dextran-FITC and transferrin-
FITC, respectively, were incubated with granulysin132. In neither
the initial uptake nor in the later stages was dextran (Fig. 4C) or
transferrin (data not shown) colocalized with granulysin132.
Preincubation of DC with MCD, which is known to disrupt lipid
raft-mediated uptake by binding cholesterol (39), inhibited the up-
take, but not the binding, of granulysin132 in DC. After incubation
of DC with MCD for 45 min at 37°C, granulysin132 was detected
in patches at the cell membrane (Fig. 4A). In contrast, simulta-
neously applied dextran-FITC was endocytosed by cholesterol-de-
pleted cells at 37°C, indicating that the fluid phase endocytosis was
still functional. After incubation of cholesterol-depleted cells at
4°C, both granulysin132 and dextran-FITC were found at the cell
membrane, but no intracellular staining was detected (Fig. 4B). In
control cells pretreated with serum-free medium, uptake of both
granulysin132 and dextran-FITC was detected at 37°C (Fig. 4C).
Similar results were obtained by pretreatment of DC with filipin (1
g/ml), another lipid raft-disrupting drug (38), before granuly-
sin132 incubation (not shown). Overall, these findings revealed
lipid rafts to be critically involved in initial uptake, but not binding
of granulysin to DC.
FIGURE 2. Granulysin132 is actively taken up by human DC. Unchal-
lenged DC were incubated for 45 min with 2.5 M granulysin132 at 37°C
(A) or 4°C (B) or with 2.5 M actinfrag at 37°C (C). After the incubation,
the cells were fixed and stained with the anti-His Ab for CLSM. Repre-
sentative phase contrast (right panels) and immunofluorescence images
(left panels) are shown. Bar  8 m. D, Granulysin132 was pretreated with
CAH, BAD, or sodium borate buffer before incubation with DC for 60 min
at 4°C. The level of bound granulysin was assessed by Western blotting.
Granulysin was detected with the anti-granulysin Ab. As a reference band,
cellular actin was detected using an anti-actin mAb. E, The activity of
modified granulysin132 against L. innocua in suspension was tested with
turbidimetry and calculated from bacterial growth curves.
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Granulysin was found in early endosomes, but not in lysosomes
To follow trafficking of granulysin132 from lipid rafts, double la-
beling of granulysin132 with markers specific for the endocytic
compartment was performed. In a first step, early endosomes were
stained with a polyclonal Ab recognizing the EEA-1. Granuly-
sin132 was colocalized with the EEA-1 (Fig. 5A) in L. innocua-
challenged DC after 10 min of incubation. After 60 min, the long-
est time analyzed for EEA-1 colocalization, granulysin132 still
resided in endosomes.
Immunostaining of L. innocua-challenged and granulysin132-
treated DC with an Ab recognizing LAMP-1 revealed that granu-
lysin132 clearly separated from the LAMP-1-positive compartment
(Fig. 5B). DAPI-stained listerial DNA was found in the lysosomal,
LAMP-1-positive compartment (arrowheads in Fig. 5B) or in
phagosomes, which showed a distinct labeling for granulysin132
(arrows in Fig. 5B). Positive staining of L. innocua for granuly-
sin132 remained detectable even when bacteria were isolated from
granulysin132-treated DC (data not shown). Overall, these results
indicate that after uptake, granulysin is present in early sorting
endosomes of DC and then transferred to phagosomes, where
granulysin is able to bind Listeria.
Granulysin mediates lysis of L. innocua in DC
L. innocua-challenged DC were incubated with various concentra-
tions of granulysin132 or granulysin145 without His-tag for 3 h at
37°C. The viability of the intracellular bacteria was tested in CFU
assays (Fig. 6A). Granulysin132 (5 M) killed 41%, and 5 M
granulysin145 killed46% of the intracellular L. innocua after 3 h.
Granulysin132 (2.5 M) was sufficient to lyse 29% of the intracel-
lular Listeria, very similar to 2.5 M granulysin145, which killed
26%. Viability reduction of bacteria was strictly dependent on
granulysin132 dosage and did not occur with actinfrag treatment.
FIGURE 3. Granulysin binding and uptake in DC are associated with
lipid rafts. L. innocua-challenged DC were coincubated with granulysin
(2.5 ; granulysin132 (A and B) or granulysin145 without His-tag (C and
D)) and FITC-labeled cholera toxin (CT; 10 g/ml) for 30 min at 37°C (A
and C) or 4°C (B and D). E and F, For pulse-chase experiments, DC were
pulsed with granulysin132 and cholera toxin for 10 min at 4°C and subse-
quently cultivated at 37°C for the indicated chase periods. Granulysin132 is
marked in red, cholera toxin is shown in green, and nuclear and bacterial
DNA are stained with DAPI (blue; merged image (E), calculated colocal-
ization (F)). G, Double labeling of granulysin-treated DC with an anti-
CD55 Ab and the anti-granulysin Ab. Granulysin132 is marked in red, and
CD55 is shown in green. Colocalization images of granulysin132 and chol-
era toxin or CD55 were calculated using Imaris software. Bars  8 m.
FIGURE 4. Cholesterol depletion prevents granulysin132 uptake, but not
binding. DC were pretreated with 20 mM MCD for 45 min before incu-
bation with granulysin132 (2.5 ) and dextran-FITC (1 mg/ml) for 45 min
at 37°C (A) or 4°C (B). C, Control cells were pretreated with serum-free
medium for 45 min before incubation with granulysin132 and dextran-FITC
for 45 min at 37°C. Bars  8 m.
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Incubation of DC with granulysin132 at 4°C for 3 h did not impair
the viability of intracellular L. innocua (data not shown). To ex-
clude bacteria loss due to detachment of perishing host cells, the
viability of DC after granulysin132 incubation was assessed.
Granulysin132 incubated in a concentration up to 5 M had no
effect on the viability of L. innocua-challenged DC monitored in
lactate dehydrogenase release and thiazolyl blue (MTT) assays
(data not shown).
Compared with the fast lysis of extracellular L. innocua, intra-
cellular bacterial killing was delayed. Forty-five minutes of incu-
bation at 37°C with 2.5 M granulysin132 was required to kill 12%
of the intracellular bacteria (Fig. 6B). Intracellular lysis increased
LAMP-1, cells were treated for 90 min with 2.5 M granulysin132 at 37°C,
then stained with a polyclonal anti-granulysin Ab and a polyclonal Ab
recognizing EEA-1 or an anti-LAMP-1 mAb, respectively. Nuclear and
bacterial DNA was labeled with DAPI (blue); early endosomes and lyso-
somes, respectively, are marked in green; and granulysin132 is depicted in
red. The yellow spots in the merge image (A) indicate colocalization of
granulysin132 with EEA-1. Colocalization of the green and red channels
was additionally calculated using Imaris software. Arrowheads in B indi-
cate listerial DNA spots that colocalize with LAMP-1, whereas arrows
mark DNA spots that coincide with granulysin132. Bar  8 m.
FIGURE 5. Granulysin132 is localized in early endosomes and Listeria-
containing phagosomes, but not in lysosomes. A, L. innocua-challenged
DC were incubated with 2.5 M granulysin132 for 30 min at 37°C for
colocalization with EEA-1. B, For double staining of granulysin132 and
FIGURE 6. Granulysin132 mediates lysis of L. innocua in DC. L. in-
nocua-challenged DCs were incubated for 3 h with granulysin132 in vary-
ing concentrations (A) or with 2.5 M granulysin132 for the indicated time
periods at 37°C (B). After granulysin132 incubation, cells were lysed in
ice-cold water, and Listeria viability was assessed in CFU assays. The
mean  SD of four independent experiments are presented. C, Deconvo-
luted CLSM image of intracellular bacteria found in granulysin-treated DC.
Bacterial DNA (red) is stained with DAPI, and granulysin132 (green) is
labeled with an anti-His Ab. Bar  2 m. D, L. innocua-challenged DC
were cholesterol-depleted for 45 min with the indicated concentrations of
MCD. Subsequently, DC were incubated with 2.5  granulysin132 for 3 h
at 37°C. After the incubation, cells were lysed, and bacterial viability was
assessed in CFU assays. The mean SE of three independent experiments
are presented. Statistical significance was calculated with Student’s t test
for paired samples.
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to 25% after 90 min of treatment, but never reached the same level
as in suspension (see Fig. 1B). The maximal reduction of 31% of
the intracellular bacteria was achieved after 3 h of incubation with
2.5 M granulysin132. Deconvoluted high resolution CLSM im-
ages of L. innocua within granulysin132-treated DC demonstrated
bacterial DNA that was clearly surrounded by granulysin132 label-
ing (Fig. 6C). Granulysin132-mediated lysis of intracellular L. in-
nocua was reduced after cholesterol depletion of DC by MCD in
a dose-dependent manner (Fig. 6D). Preincubation of DC with 10
mM MCD diminished lysis of intracellular L. innocua to 13%, and
only 4% of specific lysis was achieved after pretreatment with 20
mM MCD.
Discussion
In this study we could clearly demonstrate that recombinant granu-
lysin was binding and dose-dependently killing L. innocua as free
bacteria grown in suspension. Granulysin-induced lysis of Listeria
is in agreement with data obtained by other groups using a variety
of microbial pathogens, including L. monocytogenes (8, 20). To
date, the binding of granulysin to bacteria has never been directly
shown, but can be explained by properties of the SAPLIP family,
of which granulysin is a member. SAPLIPs interact with a variety
of lipids (14). Bacterial membranes contain mainly acidic phos-
pholipids, such as phosphatidylglycerol and cardiolipin. Positive
charges of granulysin (net charge, 11) can be assumed to be the
driving force for binding to negatively charged bacterial mem-
branes. Charges in granulysin are not homogeneously distributed,
but are slightly polarized toward a region of the molecule corre-
sponding to helix 3 (19). This region was proposed as the site of
the initial contact of granulysin to bacterial membranes. After
binding, granulysin is suggested to cluster at the bacterial mem-
brane, leading to deformation and, subsequently, lysis by friction
of adjacent granulysin molecules.
To reach intracellular bacteria, granulysin has to bind and enter
mammalian cells that have apparent differences in the composition
of membranes to prokaryotes. The outer leaflet of mammalian cells
is mainly composed of zwitterionic phospholipids, such as phos-
phatidylcholine and sphingomyelin. Cholesterol is abundant in
mammalian cells, but is absent in bacterial cell membranes. A third
difference is the higher transmembrane potential of prokaryotic
cells (40–43).
Binding of granulysin to mammalian cell membranes can again
be explained by properties of the SAPLIP family. The interaction
of saposins with sphingolipids has been extensively investigated.
Dependent on the pH value, all saposins were reported to bind the
negatively charged gangliosides, which are found enriched to-
gether with cholesterol in lipid rafts. In our study we could show
by modifying arginine residues of granulysin that positive charges
of arginine residues contribute crucially to the lytic activity against
L. innocua as well as to the binding capacity to DC membranes.
Lysine residues seem not to play an important role in lysis of
bacteria and binding to eukaryotic cells. This is consistent with the
finding that covering the granulysin arginine residues by butane-
dione reduced binding and lysis of E. coli (20). Granulysin was
found bound to lipid rafts, as indicated by its colocalization with
cholera toxin and CD55, both known markers for lipid rafts (25,
38, 44). Preincubation of cells with MCD or filipin, which are both
known to deplete cholesterol (45), did not abolish binding of
granulysin to lipid rafts. Mechanisms of granulysin binding to lipid
rafts or even binding partners are still an enigma, but it is known
to be cholesterol independent. Clustering of granulysin at gangli-
oside-rich regions of the plasma membrane could apply local shear
stress that might trigger budding and subsequently endocytosis of
granulysin-containing membrane vesicles. There is some evidence
that local deformation and membrane tension contribute to the reg-
ulation of endocytosis (46, 47).
In contrast to binding, uptake of granulysin could be inhibited
by cholesterol depletion, but also by incubation at 4°C. Inhibition
of uptake at 4°C is a strong indication for an active process (48).
Endocytosis of granulysin via the lipid raft/caveolae pathway is
distinguished from both the clathrin-dependent and constitutive
pinocytic pathways by its sensitivity to cholesterol depletion. In
line with this observation is that dextran or transferrin as tracers for
constitutive pinocytosis and clathrin-dependent pathway, respec-
tively, were never found colocalized with simultaneously applied
granulysin. After endocytosis, granulysin was found to be sorted
differently from cholera toxin (49). Additional intracellular traf-
ficking of granulysin from early endosomes may result in fusion of
endosomes with phagosomes where granulysin was found to be
colocalized with bacteria. Fusion of granulysin-containing early
endosomes with phagosomes may be regulated by the small rab5
GTPase, which has been shown to be directly correlated with an
accelerated maturation of Listeria-containing phagosomes (50).
In our model of L. innocua-challenged human DC binding, up-
take and trafficking of granulysin to phagosomes as well as binding
to and lysis of L. innocua were shown to occur in the absence of
perforin. In contrast to these results, it was shown that M. tuber-
culosis was efficiently lysed in vitro in human DC by granulysin
only in combination with perforin (8, 20). This combination of
perforin and granulysin to achieve antibacterial activity against
intracellular pathogens seems necessary at least occasionally. NKT
cells and CTL could control mycobacterial infection by relying on
granulysin, but not on perforin or Fas/Fas ligand interaction (11,
29). In vivo, it was found that perforin-negative, but granulysin-
positive, CD4 cells are present at sites of bacterial infections (12,
13). This is in line with our in vitro data for granulysin activity.
However, data are largely missing about the exact role of perforin
in lysis of intracellular bacteria, e.g., M. tuberculosis. Data on
perforin-dependent as well as independent uptake and activity of
granulysin are not conclusive, and mechanisms of entry into host
cells are poorly characterized. Perforin might well have a role in
granulysin trafficking to compartments harboring intracellular bac-
teria. In contrast to apathogenic L. innocua pathogenic species
such as M. tuberculosis, Chlamydia spp. and Coxiella spp. have
evolved strategies to modify their intracellular compartments (51,
52) or are known to escape from vesicular compartments to the
cytosol-like L. monocytogenes (53). Mycobactera, for example,
can stop phagosome maturation by inhibiting acquisition of the
rab5 effector EEA-1. By excluding this important regulator for
vesicular trafficking, fusion processes within the endocytic path-
way are impaired (54).
Overall, we propose a model of granulysin-mediated activity
against intravacuolar bacteria. According to this model, binding
due to electrostatic interactions and clustering of granulysin at
membrane microdomains with elevated acidic sphingolipid con-
tent would lead to endocytosis as a first step toward lysis of in-
tracellular bacteria. Such lipid raft microdomains were indeed
found concentrated in the regions of the immunological synapse
(55). After cholesterol-dependent uptake, granulysin is delivered
to early sorting endosomes, fusing later with bacteria-harboring
phagosomes, where the lysis of the bacteria is induced. Simulta-
neously secreted IFN- at sites of infection by the CTL would
enhance granulysin targeting. There is evidence that activated
macrophages up-regulate rab5 in response to IFN- (56). An ele-
vated level of rab5 accelerates not only maturation of Listeria-
containing phagosomes (50), but also the likelihood for phago-
some-endosome fusion. Thus, the antimicrobial activity mediated
by granulysin would be enhanced.
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Abstract. The release of granulysin, a 9-kDa cationic
protein, from lysosomal granules of cytotoxic T
lymphocytes and natural killer cells plays an impor-
tant role in host defense against microbial pathogens.
Granulysin is endocytosed by the infected target cell
via lipid rafts and kills subsequently intracellular
bacteria. The mechanism by which granulysin binds
to eukaryotic and prokaryotic cells but lyses only the
latter is not well understood. We have studied the
eﬀect of granulysin on large unilamellar vesicles
(LUVs) and supported bilayers with prokaryotic and
eukaryotic lipid mixtures or model membranes with
various lipid compositions and charges. Binding of
granulysin to bilayers with negative charges, as typi-
cally found in bacteria and lipid rafts of eukaryotic
cells, was shown by immunoblotting. Fluorescence
release assays using LUV revealed an increase in
permeability of prokaryotic, negatively charged and
lipid raft-like bilayers devoid of cholesterol. Changes
in permeability of these bilayers could be correlated to
defects of various sizes penetrating supported bilayers
as shown by atomic force microscopy. Based on these
results, we conclude that granulysin causes defects in
negatively charged cholesterol-free membranes, a
membrane composition typically found in bacteria. In
contrast, granulysin is able to bind to lipid rafts in
eukaryotic cell membranes, where it is taken up by the
endocytotic pathway, leaving the cell intact.
Key words: Cholesterol — Lipid bilayer —
Granulysin — AFM — Cytotoxicity — Lipid rafts
Introduction
Cytotoxic T lymphocytes (CTLs) and natural killer
(NK) cells contribute to the host defense against
intracellular pathogens by release of cytokines that
activate antimicrobial eﬀector pathways (Flynn et al.,
1993) and lyse infected target cells by induction of
apoptosis (Kaspar et al., 2001; Smyth et al., 2001) or by
exocytosis of cytotoxic proteins, such as perforin and
granulysin, which are stored in lysosomes (Kaufmann,
1999; Pena & Krensky, 1997). Granulysin is expressed
constitutively in NK cells and cytotoxic T cells
and upregulated following antigen-driven activation
(Pena & Krensky, 1997; Stegelmann et al., 2005). It is
released from the cytotoxic granules after cellular
stimulation and is active against a broad range of
intracellular pathogens, such as Listeria monocytoge-
nes, Mycobacterium tuberculosis and Trypanosoma
cruzi (Clayberger & Krensky, 2003; Krensky, 2000;
Stenger et al., 1998; Walch et al., 2005).
Granulysin is a 9-kDa protein and belongs to the
saposin-like protein (SAPLIP) family, which includes
amebapores (Bruhn & Leippe, 1999), NK-lysin
(Liepinsh et al., 1997) and saposins A, B, C and
D (Clayberger & Krensky, 2003; Krensky, 2000;
Morimoto et al., 1988, 1989; O¢Brien & Kishimoto,
1991; Qi & Grabowski, 2001). The family members
are cationic proteins, and they share a particular
polypeptide motif of a ﬁve-helix bundle and highly
conserved cysteine residues that form disulﬁde bonds
(Munford, Sheppard & O¢Hara, 1995), which give the
molecule a stable structure. They interact with a
variety of lipids, especially cholesterol (Vaccaro et al.,
1995) and sphingolipids (Vaccaro et al., 1999).
Comparing the amino acid sequences of the SAPLIP
family members reveals that granulysin has the
highest identity to NK-lysin (43% identity), a porcine
protein with antibacterial activity (Andersson et al.,
Correspondence to: Urs Ziegler; email: ziegler@anatom.unizh.ch
Max Dolder¢s present address is: Institute of Medical Microbiol-
ogy, University of Zurich, Gloriastrasse 32, CH-8006 Zurich,
Switzerland
J. Membrane Biol. 212, 29–39 (2006)
DOI: 10.1007/s00232-006-0040-3
34
1995). Although the SAPLIP family members have
structural similarities, they have various biological
functions: amebapores are capable of forming ion
channels or pores in lipid membranes (Lynch,
Rosenberg & Gitler, 1982; Young et al., 1982),
saposin A-D modify the membrane to become sub-
strates for enzymes and granulysin and NK-lysin
appear to directly permeabilize bacterial membranes
(Anderson et al., 2003; Krensky, 2000).
Recently, it has been found that granulysin binds
to infected cells via lipid rafts (Walch et al., 2005),
which are specialized membrane microdomains
(Simons & Ikonen, 1997). Lipid rafts consist of
phospholipids and cholesterol in the inner membrane
leaﬂet and sphingomyelin and cholesterol in the outer
membrane leaﬂet, and they are involved in a variety
of cellular functions including endocytosis (Brown &
London, 2000; Cambi et al., 2004; Manes, del Real &
Martinez, 2003). Cholesterol has an important role in
lipid rafts and in lipid bilayers, which usually exist in
an ordered gel phase under the transition temperature
of their lipids. However, cholesterol is able to eradi-
cate the sharp transition between ordered gel phase
and liquid crystalline phase, resulting in a liquid or-
dered phase, where the lipids have a high degree of
lateral mobility as well as tightly packed acyl chains
(Brown & London, 2000; McMullen & McElhaney,
1997; Pralle et al., 2000; Simons & Ikonen, 1997).
The lipid raft-bound granulysin is endocytosed
and transferred via membrane vesicles to early
endosomes and then to phagosomes. Subsequently,
bacteria are killed by granulysin via membranolysis,
whereas binding and intracellular traﬃcking of
granulysin do not harm the target cell (Brown &
London, 2000; Walch et al., 2005). Therefore, one
important feature of granulysin is its ability to dis-
tinguish between prokaryotic and eukaryotic cells,
which diﬀer in the lipid composition of their mem-
branes. A eukaryotic cell membrane consists of cho-
lesterol, sphingomyelin and phospholipids, such as
phosphatidylcholine (PC), phosphatidylethanolamine
(PE), phosphatidylserine (PS) and phosphatidylglyc-
erol (PG), whereas the membrane of a prokaryotic
cell lacks cholesterol and sphingomyelin, consisting
mainly of cardiolipin, PC, PE, PS and PG, from
which cardiolipin, PC, PE and PG are found in both
membrane leaﬂets whereas PS is mainly located in the
cytoplasmic leaﬂet (Gidalevitz et al., 2003; Kurz
et al., 2005; Pomorski et al., 2004; Tannert et al.,
2003).
Our hypothesis is that granulysin binds to
and permeabilizes negatively charged phospholipid
membranes typically found in bacteria but does not
permeabilize target cell membranes when bound to
lipid rafts or phospholipid membranes with eukary-
otic lipid compositions. Experiments were performed
to analyze the eﬀect of granulysin on membranes with
prokaryotic and eukaryotic lipid mixtures as well as
on model membranes, which are commonly used to
study the behavior of biological membranes (Bacia
et al., 2004; Giocondi et al., 2004; Jass, Tjarnhage &
Puu, 2000; Tong & McIntosh, 2004). We used
membranes with negative and uncharged phospho-
lipid compositions as well as lipid raft-like mem-
branes. Fluorescence release assays were used to
analyze the activity of granulysin and ultracentrifu-
gation and immunoblotting, to study the binding of
granulysin to membranes with diﬀerent lipid com-
positions. To further investigate the eﬀect of gra-
nulysin on membranes, atomic force microscopy
(AFM) was used to visualize morphological changes
of granulysin-treated membranes.
Our ﬁndings indicate a strong dependence on
membrane lipid composition and cholesterol content
for granulysin-mediated eﬀects against bacterial and
eukaryotic cell membranes.
Materials and Methods
MATERIALS
1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), 1-pal-
mitoyl-2-oleoyl-sn-glycero-3-phospho-rac-(1-glycerol) (POPG),
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 2-oleoyl-1-
palmitoyl-sn-glycero-3-phosphocholine (POPC), choles-
terol, sphingomyelin from chicken egg yolk (SM) (Sigma-Aldrich,
St. Louis, MO), 1,1¢,2,2¢-tetramyristoyl cardiolipin and Escherichia
coli total lipid extract (Avanti Polar Lipids, Alabaster, AL) were
stored in a chloroform:methanol (2:1) solution. The ﬂuorescent
lipid dye 2-(4,4-diﬂuoro-5-methyl-4-bora-3a,4a-diaza-s-indancene-3-
dodecanoyl)-1-hexadecanoyl-sn-glycero-3-phosphocholinen-b-Bodipy
(PC-b-Bodipy) was purchased from Molecular Probes (Eugene,
OR), and water was obtained from a Millipore (Billerica, MA)
water puriﬁcation system.
EXPRESSION AND PURIFICATION OF RECOMBINANT
GRANULYSIN
Recombinant granulysin and a fragment of human b-actin (actin
fragment) were cloned, expressed and puriﬁed according to
Walch et al. (2005). Brieﬂy, histidine-tagged recombinant pro-
teins were puriﬁed by nickel aﬃnity chromatography (A¨KTA
Prime; Amersham Biosciences, Uppsala, Sweden) using Ni-NTA
agarose (Qiagen, Hilden, Germany). The eluted protein was di-
luted in 6 M guanidine-HCl and renatured in 0.75 M arginine,
0.05 M Tris-HCl (pH 8), 0.05 M KCl, 0.001 M ethylenediamine-
tetraacetic acid (EDTA) and 0.01 M oxidized dithiothreitol
(Sigma-Aldrich) at a 1:10 dilution with constant stirring at 4C
for 48 h and further puriﬁed using Sep-Pac Vac 6cc (1 g) C18
cartridges (Waters, Milford, MA), from where it was eluted
with 100% acetonitrile containing 0.1% triﬂuoroacetic acid and
lyophilized. Protein concentration was determined using a Bio-
Rad (Hercules, CA) protein assay, and purity was estimated by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE). Activity of recombinant proteins was tested according
to Walch et al. (2005) using Listeria innocua in a turbidimetry
assay.
30 H. Barman et al.: Cholesterol Modulates Granulysin Eﬀects
35
EXTRACTION OF MEMBRANE LIPIDS
Membrane lipids were extracted from L. innocua, Hep-2 cells and
human erythrocytes according to the following procedure. Cells
(20 ml erythrocytes from Buﬀy Coat; Blood Bank SRK, Zu¨rich,
Switzerland) and bacteria (1 liter Tryptic Soy Broth [TSB, Becton
Dickinson, Le Pont de Claix, France] culture, optical density
[OD]600 = 0.8) were centrifuged at 500 · g for 10 min at 4C,
resolved in 10 ml sterile water, mixed with 20 ml isopropanol and
incubated with occasional shaking for 1 h at room temperature.
Chloroform (20 ml) was added to the solution, and the mixture
was incubated for another hour at room temperature, followed
by centrifugation at 500 · g for 30 min at 4C. The lipid extract
was mixed with 10 ml chloroform:methanol (2:1) and washed
with 0.2 volumes of 0.05 M KCl. The purity of the lipids was
tested by thin-layer chromatography, and the lipid extracts were
stored at )20C.
PREPARING LARGE UNILAMELLAR VESICLES AND
SUPPORTED LIPID BILAYERS
E. coli, L. innocua, Hep-2 and erythrocyte lipid extracts, as well as
negatively charged phospholipid (POPG:DPPC 1:2, POPG:DOPE
1:2, cardiolipin:DOPE 1:2 and POPG:SM:POPC 1:1:1), uncharged
phospholipid (POPC:DPPC, 1:2) and lipid raft-like lipid mixtures
(POPG:cholesterol:SM 1:1:1, POPG:cholesterol:POPC 1:1:1) were
dissolved in 20 ml chloroform:methanol (2:1, ﬁnal lipid concen-
tration of approximately 0.5 mg/ml) and evaporated to dryness for
5 min at 500 mbar, 15 min at 250 mbar, 60 min at 150 mbar and
180 min at 100 mbar (Rotavapor; Bu¨chi Labortechnik, Flawil,
Switzerland). The dried lipid ﬁlms were rehydrated in buﬀer (0.05 M
Tris-HCl, 0.15 M NaCl and 0.001 M CaCl2, pH 7.2) containing
12.5 lM of the ﬂuorescent probe 8-aminonaphthalene-1,3,6-trisul-
fon acid, disodium salt (ANTS), and 45 lM of the collisional
quencher p-xylene-bis-pyridinium bromide (DPX, Molecular
Probes) by shaking with 220 rpm for 20 min at 47C. For pH-
dependence measurements, the dried lipid ﬁlms were rehydrated in
Pipes buﬀer at pH 5 and pH 7.2 (0.05 M Pipes, 0.15 M NaCl and
0.001 M CaCl2). The liposome suspensions were extruded through a
polycarbonate membrane with a pore diameter of 400 nm (Avestin,
Ottawa, Canada) using a Liposofast extruder (Avestin) at 47C for
formation of large unilamellar vesicles (LUVs), which were puriﬁed
from excess ANTS and DPX using gel ﬁltration chromatogra-
phy (10 desalting Grade [DG], Bio-Rad) and diluted to a ﬁnal lipid
concentration of 0.1–1 mg/ml.
Supported lipid bilayers were formed by depositing 80 ll
LUV suspension onto a freshly cleaved mica surface with an area
of 0.8 cm2. After a 2 h incubation at 37C for formation of patches
of bilayers or at 50C for testing the formation of bilayers with
liquid crystalline and ordered gel phase separation, the specimens
were cooled down to room temperature, gently rinsed with buﬀer
and analyzed by AFM or confocal laser scanning microscopy.
FLUORESCENCE RELEASE ASSAYS
Granulysin was incubated at various concentrations with LUV in
0.05 M Tris-HCl, 0.15 M NaCl and 0.001 M CaCl2 (pH 7.2) in a
FluoroNunc 96-well plate (Nunc, Roskilde, Denmark). Cloned
actin fragment and buﬀer were used as controls, and 0.1% Triton-X
100 (Sigma-Aldrich) was used for measurement of 100% lysis
(ﬂuorescence release, FR100%). ANTS ﬂuorescence release was
monitored in a DTX-880 multimode detector (Beckman Coulter,
Fullerton, CA) at kexcitation = 370 nm, kemission = 535 nm and the
percentage ﬂuorescence release was calculated using the formula
[(FRgranulysin – FRblank)/(FR100% ) FRblank)] x 100.
ULTRACENTRIFUGATION AND WESTERN BLOT ANALYSIS
LUVs were incubated in buﬀer solution (0.05 M Tris-HCl, 0.15 M
NaCl and 0.001 M CaCl2, pH 7.2) with 5 lM granulysin in a
volume of 400 ll at 37C for 2 h. For some experiments, gra-
nulysin was pretreated with 2,3-butanedione (Sigma-Aldrich),
which covalently modiﬁes the guanidine group of arginine resi-
dues (Walch et al., 2005). After incubation, the LUV solution was
mixed with 1.2 ml 80% (w/v) sucrose solution, overlaid with 1 ml
50% sucrose (w/v) and 1 ml buﬀer solution. Ultracentrifugation
was performed at 140,000 x g for 90 min at 4C. Fractions (6 x
600 ll) were collected from the top and analyzed by Western
blotting (tricine gel, 16.5%) using anti C-terminal-his antibody
(1:5,000; Invitrogen, Carlsbad, CA) and a goat anti-mouse
immunoglobulin G–peroxidase-conjugated antibody (1:5,000,
Sigma-Aldrich). The signal was detected using an enhanced
chemiluminescence Western blotting detection system (Amersham
Biosciences).
AFM
Bilayers were imaged with a Bioscope Multimode AFM (Digital
Instruments, Santa Barbara, CA) in contact mode in buﬀer solu-
tion containing 0.05 M Tris-HCl, 0.15 M NaCl and 0.001 M CaCl2
(pH 7.2) using NanoProbe Si3N4 cantilevers (Digital Instruments).
The force was minimized by adjusting the set point to just under
the jump-oﬀ point of the tip. The scan rate was typically 4–5 Hz.
All images were obtained at room temperature (22C). Images were
analyzed using Nanoscope III (Digital Instruments) or Matlab
(MathWorks, Natick, MA) software.
Supported lipid bilayers with diﬀerent compositions were
imaged with AFM, then treated for 2 h at 37C with granulysin,
cooled down to room temperature, rinsed gently with buﬀer (0.05 M
Tris-HCl, 0.15 M NaCl and 0.001 M CaCl2, pH 7.2) before imaging
again. Real-time imaging could not be performed due to unspeciﬁc
interactions of proteins in solution with the tip. Actin fragment and
buﬀer were used as controls. For temperature stability experiments,
granulysin-treated samples, after imaging with AFM, were heated
to 47C for 30 min, cooled down and imaged again.
The eﬀect of antibody binding was visualized on previ-
ously imaged granulysin-treated bilayers by incubation with an anti
C-terminal-His antibody (1:5,000) on a rocking platform for 1 h at
room temperature, gently rinsed with buﬀer and subsequently im-
aged again.
CONFOCAL LASER MICROSCOPY
The changes in ﬂuidity of PC-b-Bodipy containing negatively
charged phospholipid bilayers were tested at room temperature and
47C, which is over the transition temperature of the lipids, using
ﬂuorescence recovery after photobleaching (FRAP) trials with the
confocal laser scanning microscope (Leica Microsystems, Mann-
heim, Germany).
Results
GRANULYSIN PERMEABILIZES NEGATIVELY CHARGED
CHOLESTEROL-FREE MEMBRANES
To analyze the permeabilization of vesicles by gra-
nulysin, ANTS-loaded LUVs of varying lipid com-
positions were treated with increasing concentrations
of granulysin and the released ANTS ﬂuorescence
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was measured. First, we investigated vesicles
composed of lipid extracts from prokaryotic and
eukaryotic cell membranes. Only the vesicles com-
posed of prokaryotic lipid mixtures were permeabi-
lized by granulysin, whereas vesicles composed of
eukaryotic lipid mixtures were not permeabilized
(Fig. 1A). To compare the eﬀect of granulysin on
diﬀerent lipid mixtures, PG and cardiolipin were used
as negatively charged lipids and PC and PE as un-
charged lipid throughout the following results. As
shown in Figure 1B, LUVs containing negatively
charged phospholipids were eﬀectively permeabilized
by granulysin in contrast to uncharged vesicles. A
50% permeabilization of POPG:DPPC-containing
vesicles was reached at a concentration of 0.15 lM
granulysin, cardiolipin:DOPE-containing vesicles at
0.63 lM of granulysin and POPG:DOPE-containing
vesicles at 1.25 lM of granulysin. The actin fragment
used as control could not permeabilize negatively
charged LUVs.
To investigate the eﬀect of granulysin on
eukaryote-like vesicles, we tested the membranoly-
sing eﬀect of granulysin on cholesterol-containing
lipid raft-like vesicles (POPG:cholesterol:SM). The
results showed no permeabilizing of the cholesterol-
containing vesicles. We also examined which of
the membrane components prevented the membran-
olysing eﬀect of granulysin, using vesicles containing
phospholipids and cholesterol (POPG:cholesterol:POPC)
or sphingomyelin (POPG:SM:POPC). Only choles-
terol-free vesicles were permeabilized by granulysin.
A 50% permeabilization of POPG:SM:POPC was
reached at a granulysin concentration of 0.6 lM,
whereas the cholesterol-containing vesicles were
never permeabilized (Fig. 1C).
To further strengthen the assumption that char-
ges are responsible for permeabilization of LUVs, the
pH dependence of granulysin-induced ﬂuorescence
release was studied. Negatively charged phospholipid
LUVs were treated with diﬀerent concentrations of
granulysin at pH 5 and 7.2. We found that granulysin-
induced ﬂuorescence release was more eﬃcient at
acidic than at neutral pH (Fig. 1D). A ﬂuorescence
release of 50% was reached with 0.02 lM granulysin at
pH 5, much lower than the 0.15 lM measured at pH
7.2. This higher activity correlates with the increased
positive charge of the molecule at lower pH. In con-
trast, granulysin was not able to permeabilize lipid
raft-like LUVs (POPG:cholesterol:SM) even at pH 5.
GRANULYSIN BINDS TO NEGATIVELY CHARGED AND
LIPID RAFT-LIKE MEMBRANES
Since granulysin was able to permeabilize vesicles
composed of prokaryotic lipid compositions and
negatively charged cholesterol-free vesicles, but not
A B
C D
Fig. 1. Fluorescence release assays showing granulysin-induced eﬀects on membranes with (A) E. coli (-n-), L. innocua (-h-), erythrocyte
(-m-) and Hep-2 (-s-) lipid mixtures and on (B) POPG:DPPC (-n-), cardiolipin:DOPE (-*-), POPG:DOPE (-d-) and uncharged
POPC:DPPC (-s-) phospholipid LUVs. Negatively charged LUVs treated with actin fragment (-m-) served as controls. (C) Granulysin-
induced permeabilization on DPPC:POPG (-n-), lipid raft-like POPG:cholesterol:SM (-s-), POPG:SM:POPC (-D-) and POPG:choles-
terol:POPC (-m-). (D) Eﬀect of pH on granulysin-induced permeabilization of lipid raft-like LUVs at pH 5 (-s-) and pH 7.2 (-m-) and of
negatively charged phospholipid LUVs at pH 5 (-D-) and pH 7.2 (-n-). One representative experiment out of three is shown.
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membranes with eukaryotic lipid compositions and
lipid raft-like vesicles (cholesterol-containing), bind-
ing of granulysin to vesicles with diﬀerent composi-
tions was studied. To this end, granulysin-treated
LUVs were analyzed by ultracentrifugation and
Western blotting. Interestingly, granulysin did not
bind only to LUVs exhibiting distinct ﬂuorescence
release but to all LUVs containing negatively charged
lipids, including lipid raft-like LUVs and LUVs
composed of eukaryotic lipid mixtures (Fig. 2).
Granulysin bound to LUVs was located in low-den-
sity fractions (fractions 1–2) and free granulysin in
high-density fractions (fractions 4–6).
To study the importance of arginine residues for
membrane binding, granulysin was pretreated with
2,3-butanedione (BAD) to block positively charged
arginine residues. We found that BAD treatment
abolished the binding of granulysin to negatively
charged LUVs (Fig. 2H), supporting previous
observations (Walch et al., 2005).
GRANULYSIN INDUCED DEFECTS ON SUPPORTED LIPID
BILAYERS
Due to the fact that granulysin binds to negatively
charged phospholipid and all lipid raft-like LUVs but
permeabilizes only negatively charged cholesterol-
free LUVs, we visualized the granulysin-induced
changes in supported lipid bilayers using AFM.
LUVs were attached on mica, where they formed
bilayers with irregularly shaped borders (Fig. 3) and
diameters varying between 0.3 and 3 lm. The height
of the bilayers was 4.5 ± 1 nm in accordance with
the thickness of cell membranes (Chamberlain &
Bowie, 2004). Domain separations could be visual-
ized by AFM only in samples prepared over the
transition temperatures for the lipids, at 50C (data
not shown). However, to obtain more contrast in the
images by visualizing also the mica surface and not
only the phospholipid bilayers, we prepared the
samples at 37C. This procedure oﬀered the possi-
bility to compare the heights of bilayers to those of
the defects.
Untreated (Fig. 3A, C, E, H, J, L) and 5 lM
granulysin-treated (Fig. 3B, D, F, I, K, M) lipid
extract supported bilayers of various compositions
were imaged by AFM. In prokaryotic and negatively
charged phospholipid bilayers, distinct membrane
defects were detected after treatment with granulysin
(Fig. 3B, F, I). The depth of these defects was
5 ± 1 nm, indicating that they penetrated the entire
bilayer. Untreated or actin fragment-treated nega-
tively charged phospholipid bilayers never showed
any defects (Fig. 3E, G). The bilayers composed of
erythrocyte lipids and the cholesterol-containing lipid
raft-like bilayers also showed no defects after treat-
ment with granulysin (Fig. 3K, M).
Supported lipid bilayers incubated with granuly-
sin were compared to granulysin-incubated LUVs
after ultracentrifugation to examine if the defects
were as well formed in bilayers of LUVs in suspen-
sion. After ultracentrifugation, granulysin-incubated
LUVs formed supported bilayers on mica, showing
the same irregularly shaped defects as before and only
on cholesterol-free bilayers with negative charges
(data not shown).
The concentration dependence of granulysin-in-
duced defects was analyzed by AFM imaging of
bilayers after incubation with 1 and 5 lM granulysin.
The number of defects was counted on a represen-
tative area of 25 lm2, and their diameters were
measured using Nanoscope III software. The data
were arbitrarily grouped in four size catego-
ries: £ 40, 41–80, 81–120 and ‡ 121 nm. Data are
shown for defects on negatively charged phospholipid
bilayers (POPG:DPPC and POPG:SM:POPC) in
Figure 4. At a granulysin concentration of 5 lM, a
higher percentage of defects were either 81–120 nm or
larger than 121 nm when compared with defects on
bilayers treated with 1 lM granulysin. These data
indicate a distinct correlation between the concen-
tration of granulysin and the size of the defects in
supported bilayers.
Fig. 2. Binding of granulysin (5 lM) to (A) LUVs composed of
E. coli lipid extracts, (B) erythrocyte lipid extracts, (C)
POPG:DPPC, (D) POPG:SM:POPC, (E) lipid raft-like
POPG:cholesterol:SM, (F) POPG:cholesterol and (G) uncharged
POPC:DPPC. (H) Binding of BAD-treated granulysin to nega-
tively charged phospholipid LUVs. Binding was analyzed by ul-
tracentrifugation and Western blotting. Fractions 1 and 2 contain
LUVs with bound (A-F) or without (G, H) bound granulysin, and
the unbound granulysin is in fractions 4, 5 and 6. The abbreviation
G stands for recombinant granulysin without LUVs as a control.
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Fig. 3. AFM images of supported bilayers on mica, with a corresponding trace along the white line indicating the height images. Results
show untreated (A) and 5 lM granulysin-treated bilayers composed of (B) E. coli lipid mixtures and untreated (C) and 5 lM granulysin-
treated (D) erythrocyte lipid mixtures, (E) untreated, (F) 5 lM granulysin-treated and (G) 5 lM actin fragment-treated POPG:DPPC
bilayers. (H) Untreated and (I) 5 lM granulysin-treated POPG:SM:POPC bilayers; (J, K) untreated and 5 lM granulysin-treated lipid raft-
like POPG:cholesterol:SM bilayers, respectively; (L, M) untreated and 5 lM granulysin-treated POPG:cholesterol:POPC bilayers, respec-
tively. Size of images: 2 x 2 lm, z-scale 15 nm.
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PERSISTENCE OF GRANULYSIN-MEDIATED DEFECTS
To test if granulysin-induced defects remain stable
above the transition temperature of the lipids, FRAP
experiments using confocal laser scanning micros-
copy at room temperature (Fig. 5A) and at 47C
(Fig. 5B) were performed. The result conﬁrmed a
higher recovery rate at higher membrane ﬂuidity at
47C. The persistence of granulysin-induced defects
during higher membrane ﬂuidity was tested on un-
treated negatively charged phospholipid bilayers
(Fig. 5C) and on negatively charged phospholipid
bilayers with granulysin-induced defects (Fig. 5D),
which were heated to 47C for 30 min and imaged
again after cooling to room temperature by AFM
(Fig. 5E, F). The results showed that the defects were
still visible after the membrane was heated to over the
transition temperature of the lipids (Fig. 5F).
Further evidence for the continuous and stable
presence of granulysin was obtained by treatment of
negatively charged phospholipid bilayers with gra-
nulysin and subsequently with anti-His-tag antibody.
In granulysin-treated bilayers, the typical defects were
visible (Fig. 6A). Following incubation with anti-His-
tag antibody, the defects were no longer detectable.
Instead, aggregates with a diameter of 20–120 nm and
a height of 1.5 ± 0.5 nm were found (Fig. 6B). In
untreated control specimens, the surface of the bilay-
ers remained smooth also after antibody incubation
(Fig. 6C).
Discussion
In spite of the growing interest in antimicrobial
proteins and their interactions with membranes, the
structure-related function and mechanism involved in
the contact between granulysin and prokaryotic
vs. eukaryotic cell membranes remains unclear.
Recently, we showed that granulysin destroys intra-
cellular bacteria, such as L. innocua, after binding to
and uptake via lipid rafts by the target cell (Walch et
al., 2005). This mechanism ensures that no premature
killing of the infected cell occurs with resulting release
and further spreading of intracellular bacteria.
To this end, granulysin must interact diﬀerently
with eukaryotic vs. prokaryotic cell membranes.
These membranes diﬀer in their physical and chemi-
cal properties. The major membrane components of
prokaryotic cells are phospholipids, and their mem-
branes contain higher amounts of anionic lipids than
eukaryotic cell membranes but no cholesterol or SM
(Gidalevitz et al., 2003; Huijbregts, de Kroon &
de Kruijﬀ, 2000; Simons & Ikonen, 1997; Simons
& Vaz, 2004; Slotte, 1999; Tannert et al., 2003).
This seems to be of fundamental importance for the
membrane interaction, activity and selectivity of
antimicrobial peptides, as we could show for gra-
nulysin in the present study. The behavior of gra-
nulysin, when coming in contact with eukaryote- and
prokaryote-like membranes, was mirrored by the use
of cell or bacterial lipid extracts. The model mem-
branes consisted of phospholipids and sterols. They
were chosen for their biological interest of being a
component of the eukaryotic or prokaryotic mem-
brane or for their ability to stabilize the model system
and simplify imaging. Our experiments on LUVs
revealed that granulysin binds to cholesterol-con-
taining membranes, generally found in eukaryotic
membranes, but is not able to permeabilize them,
conﬁrming the observation made on infected cells
(Walch et al., 2005), whereas granulysin is able to
bind and permeabilize prokaryotic membranes, as we
showed for E. coli and L. innocua membranes, and
BA
Fig. 4. Concentration
dependence of granulysin-
induced defects. The number
of defects was calculated and
the size measured on an area
of 25 lm2 of 1 lM (open
bars) and 5 lM (solid bars)
granulysin-treated bilayers
from AFM images. The
defects were classiﬁed into
groups according to
size: £ 40, 41–80, 81–120
and ‡121 nm. The results
are shown for negatively
charged phospholipid
bilayers with (A)
POPG:DPPC and (B)
POPG:SM:POPC lipid
mixtures.
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cholesterol-free negatively charged phospholipid
model membranes. Our results regarding the activity
of granulysin against prokaryotic membranes are
in agreement with a recent study by Ramamoorthy
et al. (2006). They showed that a granulysin-derived
peptide, G15, is able to bind and disrupt E. coli
outer membranes. They also demonstrated that
G15 is not able to bind to cholesterol-containing
(POPC:POPG:cholesterol) membranes. We could
show that recombinant granulysin binds to all nega-
tively charged membranes, as well as cholesterol-
containing lipid raft-like membranes, typically found
in eukaryotes. This indicates that other domains must
be responsible for binding to cholesterol-containing
negatively charged membranes.
The essential components in the formation of
lipid rafts are cholesterol and SM (Simons & Ikonen,
1997), which form a hydrogen bond between the 3b-
OH group of cholesterol and the amide group of SM.
This hydrogen bond is responsible for the tight
packing of lipid rafts but still ensures a high degree of
lipid mobility (Brown, 1998; Mombelli et al., 2003).
The tight packing in liquid ordered phase of lipid
rafts can additionally be formed between cholesterol
and phospholipids (Ohtake, Schebor & de Pablo,
2006). The acyl chains between the phospholipids are
held together by van der Waals interactions, which
are considerably weaker than hydrogen bonds and,
therefore, responsible for a less tight membrane
packing of prokaryotic membranes and non-lipid
raft parts on the eukaryotic cell membrane (Niu &
A
C D
FE
B
Fig. 5. The level of ﬂuidity of phospholipid membranes was tested
by incorporating a ﬂuorescent dye (PC–b–Bodipy) into the bilayer
and performing FRAP experiments using confocal laser scanning
microscopy. (A, B) Fluorescence recovery compared to a control
area at room temperature and at 47C, respectively. Persistence of
the granulysin-induced defects was tested by imaging (C) untreated
and (D) 5 lM granulysin-treated negatively charged phospholipid
bilayers and then heating the (E) untreated and (F) treated bilayers
over the transition temperature (47C) before imaging again in
AFM. Size of images: 2 x 2 lm, z-scale 15 nm.
A
B
C
Fig. 6. Detection of granulysin binding with anti-His-tag antibody.
Supported negatively charged phospholipid bilayers were incu-
bated with 5 lM granulysin and imaged via AFM showing typical
defects (A). The specimens which were subsequently incubated
with anti-His-tag antibody displayed various aggregates of
1.5 ± 0.5 nm height (B). The surface of untreated bilayers
remained smooth after antibody incubation (C). Size of images:
2 x 2 lm, z-scale 15 nm.
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Litman, 2002), which contain less cholesterol than
lipid rafts (Arispe & Doh, 2002).
We also found that granulysin is more active
in permeabilizing negatively charged phospholipid
LUVs at lower pH values and that BAD-treated
granulysin, due to the modiﬁed arginine residues,
cannot bind to negatively charged vesicles, in agree-
ment with the diﬀerent positive charge of the protein
at various pH values. At neutral pH granulysin has a
net charge of 8, whereas at pH 5 the net charge is 10.
Hanson et al. (1999) showed previously, using ﬂuo-
rescence release assays, that granulysin acts in a
pH-dependent manner; but, in contrast to our results,
they found that granulysin is less active at lower pH
values. Our data indicate that the protection from
lysis of granula may stem from the lipid composition
of the membrane; therefore, we suggest this to be part
of a mechanism for inhibiting the permeabilization of
granules by granulysin. In addition, the pH-depen-
dent activity might have a function in modulating the
activity of granulysin in early and late endosomes, as
well as in lysosomes and phagolysosomes, all deﬁned
stages of endocytosis. The pH in these compartments
changes from 5.9–6.0 in early endosomes to 5.0–6.0 in
late endosomes to 5.0 in lysosomes (Geisow & Evans,
1984; Renswoude et al., 1982). These diﬀerent pH
values could convert granulysin from a less active to a
highly active protein at low pH in the later stages of
endocytosis, further promoting binding to and killing
of intracellular pathogens. It is interesting to note
that traﬃcking of intracellular bacteria in the host
cell, e.g., L. innocua, is along the same route, namely
from endosomes via phagosomes to phagolysosomes,
where it can be eﬃciently lysed by granulysin (Gail-
lard et al., 1987). In the same endocytic pathway,
in the phagosomes, M. tuberculosis can be killed
(Armstrong & Hart, 1971).
The permeabilization of bacterial membranes
after binding of granulysin is supposed to originate
from oligomerization of the protein. Similar to other
cationic proteins of the SAPLIP family, the three-
dimensional structure of granulysin does not allow
the prediction of a pore (Anderson et al., 2003).
Anderson et al. (2003) propose a model for the
mechanism of action for granulysin. After oligomer-
ization, friction between granulysin molecules results
in cooperative membrane lysis and each granulysin
molecule binds to its neighboring molecules, applying
local forces to a part of the membrane. This model
correlates with the carpet model, where, ﬁrst, protein
molecules cover the infected cell by binding to the
membrane using electrostatic interactions and, sec-
ond, permeabilization of the membrane is induced
only where the protein concentration is high enough
(Anderson et al., 2003; Pouny et al., 1992; Shai,
1999).
These model predictions are in agreement with
our results. Granulysin induces defects on choles-
terol-free membranes in a concentration-dependent
manner, which is in accordance with the oligomeri-
zation of the protein bound to the bacterial mem-
brane. This is further supported by the observation of
the nonhomogeneous binding of His-tag antibodies
to granulysin-treated membranes. Binding of the
antibody also proves that granulysin stays attached
to the membrane after causing defects. Furthermore,
higher membrane ﬂuidity, as shown by varying the
temperature, does not lead to granulysin dissociation
from the membranes. The observed persistence of
granulysin-induced defects during transient ﬂuidity
changes over the transition temperatures of the lipids
suggests stable protein-protein and/or protein-lipid
interactions causing the defects to stay permanently.
In conclusion, our study showed that the com-
position and the physical properties of the membrane
are important for granulysin to interact with infected
eukaryotic host cells without aﬀecting the viability of
the cell. The cholesterol content of the host cell
membrane plays a particularly important role in the
potential of granulysin to perturb the membrane. Not
only lipid rafts but also nonraft parts of the eukary-
otic membrane contain cholesterol and can therefore
not be permeabilized, whereas granulysin is able to
bind to lipid rafts from where the protein is taken
up via endocytosis. The cholesterol-free composition
of the prokaryotic membrane is crucial for the
interaction of granulysin with intracellular patho-
gens, leading to permeabilization and ﬁnally lysis of
the bacteria. This provides important information for
understanding the function and mechanism of action
of granulysin and other positively charged antimi-
crobial proteins and how they interact with eukary-
otic and prokaryotic cell membranes.
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ABSTRACT The release of the cytotoxic protein granulysin from lysosomal granules of 
cytotoxic T lymphocytes and natural killer cells plays a central role in host defence against 
microbial pathogens. A key molecule killing intracellular bacteria is granulysin which binds 
to the infected target cells, and is endocytosed via lipid rafts. After transfer via endosomes to 
bacteria containing compartments granulysin is transferred to the bacterial cell membrane. By 
largely unknown mechanisms granulysin is inducing lysis of bacteria by a possible 
oligomerization. On prokaryotic and eukaryotic membrane a fraction of granulysin was found 
to transiently bind by surface plasmon resonance experiments. Fluorescent resonance energy 
transfer analysis of fluorescently labeled granulysin revealed oligomerization on all tested 
membranes. The fraction of irreversible bound and oligomerized granulysin was smaller on 
eukaryotic compared to prokaryotic like membranes. Based on these results we conclude that 
granulysin binds transiently to and a part of the bound granulysin oligomerizes on negatively 
charged membranes. Transient binding leads to uptake of soluble granulysin that subsequently 
oligomerizes and permeabilizes bacterial membranes.  
Introduction  
The antimicrobial protein granulysin is produced by human cytotoxic T lymphocytes (CTLs) 
and natural killer (NK) cells, which contribute to the host defence against intracellular 
pathogens by exocytosis of lysosomal granules containing granulysin and other cytotoxic 
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proteins, such as perforin and granzyme B (Kaufmann, 1999; Pena and Krensky, 1997). 
Granulysin is expressed constitutively in NK cells and CTLs, and is up-regulated following 
antigen driven activation (Pena and Krensky, 1997; Stegelmann et al., 2005). It is released 
from the cytotoxic granules after cellular stimulation and is active against a broad range of 
intracellular pathogens, such as Listeria monocytogenes, Mycobacterium tuberculosis and 
Trypanosoma cruzi (Clayberger and Krensky, 2003; Krensky, 2000; Stenger et al., 1998; 
Walch et al., 2005). 
Granulysin belongs to the saposin-like protein (SAPLIP) family, which includes amoebapores 
(Bruhn and Leippe, 1999), NK-lysin (Liepinsh et al., 1997) and saposin A, B, C and D 
(Clayberger and Krensky, 2003; Krensky, 2000; O'Brien and Kishimoto, 1991; Qi and 
Grabowski, 2001; Sasaki et al., 1998). These cationic proteins share a particular polypeptide 
motive of a five-helical bundle and highly conserved cysteine residues that form disulphide 
bonds (Munford et al., 1995). They interact with a range of lipids, particularly cholesterol 
(Vaccaro et al., 1995) and sphingolipids (Vaccaro et al., 1999).  
We showed in a previous study that granulysin interacts differently with eukaryotic and 
prokaryotic membranes (Barman et al., 2006), due to the differences in the membrane lipid 
compositions. An eukaryotic cell membrane consists of cholesterol, sphingomyelin and 
phospholipids, such as phosphatidylcholine (PC), phosphatidylethanolamine (PE), 
phosphatidylserine (PS) and phosphatidylglycerol (PG), whereas the membrane of a 
prokaryotic cell lacks cholesterol and sphingomyelin, consisting mainly of cardiolipin, PC, 
PE, PS and PG (Gidalevitz et al., 2003; Pomorski et al., 2004; Simons et al., 1992; Tannert et 
al., 2003). To understand differences in the permeabilization capacity (Barman et al., 2006) 
and the mechanism of uptake and subsequent permeabilization of bacteria by granulysin and 
other antimicrobial proteins, it is crucial to test the binding activity of granulysin on 
eukaryotic and prokaryotic membranes. 
After the initial binding to the membrane of the infected host cell, granulysin is taken up via 
lipid raft mediated endocytosis and subsequently has to reach the intracellular bacteria, bind 
to their negatively charged, cholesterol free membrane and finally lyse the bacteria (Barman 
et al., 2006; Walch et al., 2005). We visualized using the atomic force microscope the defects 
caused by granulysin on cholesterol free membranes mimicking bacterial membranes 
(Barman et al., 2006). The size of these defects is mainly between 40 nm and 120 nm, too 
large for being caused by a single molecule, suggesting that these defects could be a result 
from an oligomerization of the protein. 
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Other cytotoxic proteins, such as streptolysin O, also forms oligomers to be active (Walev et 
al., 1995). It has been shown that this toxin first binds in a monomer form to lipid bilayers, 
then the molecules collides with one another, leading to a formation of non-covalently bonded 
polymeric aggregates (Alving et al., 1979; Johnson et al., 1980; Walev et al., 1995). Also 
saposin c, which belongs to the SAPLIP family, has been shown to be able to bind to the 
membrane and then several saposin c molecules are needed to penetrate the membrane, which 
leads to membrane reorganization (You et al., 2003; You et al., 2004).  
Our hypothesis is that granulysin binds to the eukaryotic, partly oligomerizes on the 
membrane when still a large fraction of the protein stays in a monomeric form, enters then the 
cell by endocytosis, subsequently binds to and oligomerizes on the bacterial membrane, 
leading to permeabilization and lysis of the bacteria. We used membranes with negative and 
uncharged phospholipid compositions, but also membrane extracts from eukaryotic and 
prokaryotic cells. Surface plasmon resonance experiments showed the binding activity of 
granulysin, and immunoblotting revealed the oligomerization of granulysin on membranes 
with different lipid compositions. To further confirm the oligomerization of granulysin on 
membranes, fluorescence resonance energy transfer experiments were performed. 
Our findings indicate a strong dependence on the membrane lipid compositions for granulysin 
to be able to bind to membranes but also that the binding of the protein is transient. 
Additionally we showed that after the initial binding, granulysin oligomerizes on the 
membrane of both prokaryotic and eukaryotic cells. 
Materials and Methods 
Materials 
1-Palmitoyl-2-oleoyl-sn-glycero-3-phospho-rac-(1-glycerol) (POPG), 1,2-dipalmitoyl-sn-
glycero-3-phosphocholine (DPPC), 2-oleoyl-1-palmitoyl-sn-glycero-3-phosphocholine 
(POPC), cholesterol (Sigma-Aldrich, St. Louis, MO) and Escherichia coli total lipid extract 
(Avanti Polar Lipids, Inc., Alabaster, AL) were stored in a chloroform:methanol (2:1) 
solution. Streptolysin O (Sigma-Aldrich) was stored in 0.15 M Tris, pH 7.2 in -80°C, and 
activated before use with 0.025 M L-Cysteine (Sigma-Aldrich) for 10 minutes at 37°C. Water 
was obtained from a Millipore water purification system (Millipore, Billerica, MA).  
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Extraction of Membrane Lipids 
Membrane lipids were extracted from human erythrocytes according to the following 
procedure. Cells (20 ml erythrocytes from Buffy Coat, Blood Bank SRK Zürich, 
Switzerland), were centrifuged at 500 x g for 10 minutes at 4°C, resolved in 10 ml sterile 
water, mixed with 20 ml isopropanol and incubated with occasional shaking for 1 hour at 
room temperature. Chloroform, 20 ml, was added to the solution and the mixture was 
incubated another hour at room temperature, followed by a centrifugation at 500 x g for 30 
minutes at 4°C. The lipid extract was mixed with 10 ml chloroform:methanol (2:1) and 
washed with 0.2 volumes of 0.05 M KCl. The purity of the lipids was tested by TLC and the 
lipid extracts were stored at -20°C. 
Preparing large unilamellar vesicles (LUV) 
Escherichia coli and erythrocyte lipid extracts, as well as negatively charged phospholipids 
with cholesterol (POPG:DPPC:Cholesterol 1:1:1) and without cholesterol (POPG:DPPC 1:2) 
(Shany et al., 1974) as well as uncharged phospholipids with cholesterol 
(POPC:DPPC:Cholesterol 1:1:1) and without cholesterol (POPC:DPPC 1:2) were dissolved in 
20 ml chloroform:methanol (2:1) (final lipid concentration of approximately 0.5 mg/ml) and 
evaporated to dryness for 5 minutes at 500 mbar, 15 minutes at 250 mbar, 60 minutes at 150 
mbar and 180 minutes at 100 mbar (Rotavapor, Büchi Labortechnik, Flawil, Switzerland). 
The dried lipid films were rehydrated in buffer (0.05 M Tris-HCl, 0.15 M NaCl and 0.001 M 
CaCl2, pH 7.2) with or without 12.5 μM of the fluorescent probe 8-aminonaphtalene-1,3,6-
trisulfon acid, disodium salt (ANTS) and 45 μM of the collisional quencher p-xylene-bis-
pyridinium bromide (DPX) (Molecular Probes) by shaking with 220 rpm for 20 minutes at 
50°C. The liposome suspensions were extruded through a polycarbonate membrane with a 
pore diameter of 400 nm (Avestin, Ottawa, ON, Canada) using a Liposofast extruder 
(Avestin) at 50°C for formation of large unilamellar vesicles, which were purified from 
excess ANTS and DPX using gel filtration chromatography (10 Desalting Grade, Bio-Rad 
Laboratories) and diluted to a final lipid concentration of 0.1 - 1 mg/ml.  
Expression, Purification and Labelling of Recombinant Proteins 
Recombinant granulysin and a fragment of human β-actin (actinfragment) were cloned, 
expressed and purified according to Walch et al. (2005). Briefly, histidine-tagged recombinant 
proteins were purified by nickel affinity chromatography (ÄKTA prime, Amersham 
Biosciences, Uppsala, Sweden) using Ni-NTA agarose (Qiagen, Hilden, Germany). The 
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eluted protein was diluted in 6 M guanidine-HCl and renatured in 0.75 M arginine, 0.05 M 
Tris-HCl (pH 8), 0.05 M KCl, 0.001 M EDTA and 0.01 M oxidized dithiothreitol (Sigma-
Aldrich) at a 1:10 dilution with constant stirring at 4°C for 48 hours and further purified using 
Sep-Pac Vac 6cc (1 g) C18 cartridges (Waters, Milford, MA), from where it was eluted with 
100% acetonitrile containing 0.1% trifluoroacetic acid and lyophilized. Protein concentration 
was determined using Bio-Rad protein assay (Bio-Rad Laboratories, Hercules, CA) and the 
purity was estimated by SDS-PAGE. Activity of recombinant proteins was tested according to 
Walch et al. (2005) using Listeria innocua in a turbidimetry assay. Recombinant Saposin C 
was purified according to Qi and Grabowski (2001). 
Labeling Recombinant Granulysin with Alexa Fluor 488 and Alexa Fluor 595 
To label recombinant granulysin with Alexa Fluor 488 carboxylic acid or Alexa Fluor 594 
carboxylic acid (succinimidyl esters, Molecular Probes, Eugene, OR), a 2 liter E. coli culture 
was resuspended in 40 ml 0.3 M NaCl and 0.05 M NaH2PO4 with pH 8, lysed by adding 1 
mg/ml lysozyme, 1% Triton X-100, 50 µg/ml DNase, and 5 µg/ml RNase (Sigma-Aldrich), 
and bound to 250 µl Ni-NTA (Qiagen) over night in +4°C. Unbound proteins were washed 
away, the buffer was exchanged to 0.1 M NaHCO3 pH 8.3 and granulysin bound to the 
agarose was incubated over night at +4°C with 50 µl Alexa Fluor dye (2 mg/ml). The labelled 
protein was eluted with 0.3 M NaCl, 0.05 M NaH2PO4 and 0.2 M Imidazole, pH 8 and 
purified using reverse phase chromatography HPLC (Agilent Technologies Deutschland 
GmbH, Waldbronn, Germany), fractions were analysed by mass spectroscopy at the 
Functional Genomics Center in Zurich and only single labeled granulysin molecules were 
used for Fluorescence Resonance Energy Transfer experiments. 
Fluorescence Resonance Energy Transfer (FRET) 
The FRET signal of Alexa Fluor labeled granulysin was measured with a Fluorolog 4 (Horiba 
Jobin Yvon Inc, Edison NJ), by exciting at 490 nm and measuring the emission spectra from 
500 nm to 800 nm. The experiments were performed in a quartz cuvette with a volume of 130 
µl. First 130 µl of a liposome solution was measured as a blank, then 1 µM Alexa Fluor 488 
labeled granulysin was added and finally 1 µM Alexa Fluor 594 labeled granulysin. As 
control both labeled granulysins were mixed together and measured in buffer solution (0.05 M 
Tris-HCl, 0.15 M NaCl and 0.001 M CaCl2, pH 7.2). 
For the FRET experiments performed using the confocal laser scanning microscope (SP5, 
Leica Microsystems, Mannheim, Germany), the bilayers were formed in a flowcell pretreated 
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with poly-L-lysin. Granulysin labeled with Alexa Fluor 488 was bound to the membrane 
using a flow of 30 µl/min and the signal was recorded at excitation wavelength 490 nm and 
emission 520 nm. Then granulysin labeled with Alexa Fluor 594 was bound to the same 
membrane using the same flowrate, and the flow was controlled using free Cy5 dye in the 
solution, and the FRET signal was measured at emission wavelength 620 nm. 
Surface Plasmon Resonance 
Surface plasmon resonance experiments were performed with a Biacore 3000 (Biacore AB, 
Uppsala, Sweden) at the Functional Genomics Center at the University of Zürich using an L1 
chip (Biacore AB) in a buffer containing 0.05 M Tris-HCl, 0.15 M NaCl and 0.001 M CaCl2, 
pH 7.2. The flowcells were coated with 150 µl vesicles with a flow rate of 5 µl/min. The 
experiment was perfomed by comparing the binding of different concentrations of granulysin 
and the control proteins on these bilayers for an association time of 90 seconds and 
dissociation of 240 seconds at a flow rate of 60 µl/min. 
SDS-PAGE and Western Blotting 
Liposomes were incubated 1 hour together with 1 µM granulysin, mixed with either reducing 
or nonreducing sample buffer (0.2 M Tris, 40% glycerol, 4% sodium dodecyl sulphate, 0.04% 
bromophenol blue, with or without 4% β-mercaptoethanol). Reduced and nonreduced samples 
were analyzed by western blotting (15% acrylamide or 4-20% gradient acrylamide) using anti 
C-terminal-his antibody (1:5000, Invitrogen, Carlsbad, California) and a goat-anti-mouse 
IgG–peroxidase-conjugated antibody (1:5000, Sigma-Aldrich). The signal was detected using 
ECL plus western blotting detection system (Amersham Biosciences). 
Results 
Interaction of Granulysin with Immobilized Vesicles  
To analyze the binding of granulysin to bilayers, negatively charged and uncharged 
cholesterol containing LUV were immobilized on a Biacore L1 chip (Biacore AB). 
Granulysin in various concentrations (10 µM, 1 µM and 0.1 µM) was added to the bilayers 
formed on a L1 chip and the difference in the binding between the negatively charged test 
surface (POPG:DPPC:Cholesterol 1:1:1) and the uncharged control surface 
(POPC:DPPC:Cholesterol 1:1:1) was compared. The results are plotted in Figure 1A, which 
showed that granulysin bound in a concentration dependent manner to negatively charged 
cholesterol containing bilayers, in comparison to uncharged bilayers. Also the rate of 
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association of granulysin was different depending on the concentration and the shape of the 
association curve was dependent on the amount of granulysin. The higher the concentration of 
the protein, the faster it bound to the negatively charged membrane until equilibrium was 
reached. During the dissociation period when granulysin was removed from the buffer part of 
the bound material detached meaning that a part of granulysin was reversibly bound and 
possibly some lipids were removed from the bilayers. An irreversibly bound fraction of 
granulysin did not come off during the dissociation period, and this fraction of the protein was 
also dependent on the initial concentration of granulysin. As a control protein a fragment of 
human β-actin was used. This protein did not show a binding to these bilayers (Figure 1A). To 
see if sequential loading of granulysin to the negatively charged surface 
(POPG:DPPC:Cholesterol 1:1:1) leads to higher amounts of bound proteins or a changed 
binding behavior three binding and dissociation cycles were performed.. Granulysin was 
bound and detached to the bilayers during each cycle with identical binding kinetics (Figure 
1B) but with a lower net increase of granulysin irreversibly bound to the bilayer. 
Interaction of Granulysin with Prokaryotic and Eukaryotic Membranes 
To further study the binding abilities of granulysin on prokaryotic and eukaryotic membranes, 
vesicles made of lipid extracts of E. coli and human erythrocytes were used. These vesicles 
were immobilized on a L1 chip and the binding of 10 µM granulysin on these membranes was 
analyzed using the Biacore 3000, and compared with the binding of granulysin to uncharged 
phospholipid vesicles (POPC:PDDC:Cholesterol 1:1:1). The result showed clearly that 
granulysin is able to bind to both eukaryotic and prokaryotic membranes (Figure 2), and that 
it binds more to the prokaryotic membrane. Part of the protein was only reversibly bound and 
detached during the dissociation period. The rate of dissociation of the protein was slower 
compared to the dissociation of the protein bound to artificial phospholipid bilayers, but a part 
still bound irreversibly to the membrane (Figure 1). 
Interaction of Saposin C and Streptolysin O with Immobilized Vesicles 
To compare the binding of granulysin two other membrane active proteins, saposin C and 
streptolysin O, were analyzed using the Biacore 3000. Negatively charged 
(POPG:DPPC:Cholesterol and POPG:DPPC:POPC) as well as uncharged control vesicles 
(POPC:DPPC:Cholesterol) for saposin C and cholesterol free control bilayer (POPG:DPPC 
1:2) for streptolysin O were immobilized on an L1 chip and the association of saposin C and 
streptolysin O with these bilayers was studied using the Biacore 3000. Saposin C showed a 
negative response on the sensogram, when comparing the association of 10 µM of the protein 
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with the two different bilayers (Figure 3A). This means that lipids are coming off from the 
negatively charged membrane. Streptolysin O (2500 U/ml) showed a similar binding ability to 
the cholesterol containing bilayer as 1µM granulysin with fast initial binding, but the 
dissociation rate was noticeably slower than for granulysin (Figure 3B), revealing a more tight 
binding to the membrane compared to granulysin. As a control membrane for the binding 
study of streptolysin O, cholesterol free negatively charged membranes were used. 
Streptolysin O is known to bind to the membrane cholesterol (Shany et al., 1974). 
Oligomerization of Granulysin on Phospholipid Membranes 
We showed earlier using an atomic force microscope that granulysin forms defects with a size 
ranging from 40 nm to 120 nm on negatively charged cholesterol free supported lipid bilayers 
simulating the bacterial membrane (Barman et al., 2006). To prove the hypothesis that 
granulysin oligomerizes which then would lead to defects on membranes and 
permeabilization; we used fluorescence resonance energy transfer (FRET) experiments. To 
this end granulysin was labeled with either an Alexa Fluor 488 or an Alexa Fluor 594  and 
were analyzed during interaction withwith phospholipid vesicles (POPG:DPPC 1:1) by 
exciting at 490 nm and measuring the emission spectrum from 500 nm to 800 nm. The 
volume of the experiment was kept low (130µl), due to the small amounts available of the 
labeled granulysin. First the emission spectrum of granulysin labeled with Alexa Fluor 488 
together with LUV was measured, which showed an emission peak at 520 nm when excited at 
490 nm. Then granulysin labelled with Alexa Fluor 594 was added to the mixture and the 
emission spectrum was measured again when excited to 490 nm. The result, which shows an 
emission peak at both 520 nm and 620 nm, reveals a FRET signal when both Alexa Fluor 
labelled proteins were present (Figure 4A). This indicates an oligomerization of the protein. 
As a control, Alexa Fluor 488 and Alexa Fluor 594 labelled granulysin were measured 
together and separately in a buffer solution (0.05 M Tris-HCl, 0.15 M NaCl and 0.001 M 
CaCl2, pH 7.2). This experiment showed no FRET signal (Figure 4B). From this data we 
conclude that granulysin is oligomerizing when coming in contact with negatively charged 
membranes. 
The oligomerization of granulysin on phospholipid bilayers was further investigated using 
confocal laser scanning microscopy to get information about the localization of and time 
needed for oligomerization. Granulysin labeled with Alexa Fluor 488 was bound to the 
bilayers and the emission at 520 nm and 620 nm was measured after excitation at 488 nm 
(Figure 5A, C). Patches of brightly stained granulysin labeled with Alexa Fluor 488 could 
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seen when exciting with 488 nm and detecting at 520 nm (Figure 5A) but no signal at 
excitation / emission 594 nm / 620 nm (Figure 5B) or 488 nm / 620 nm (Figure 5C) could be 
seen as long as no granulysin labeled with Alexa Fluor 594 was added. After adding 
granulysin labeled with Alexa Fluor 594 to the bilayer with bound granulysin labeled with 
Alexa Fluor 488 not only the bright patches with excitation / emission 488 nm / 520 nm 
(Figure 5D) could be seen but also patches at 594 nm /620 nm (Figure 5E). Large patches 
were not found colocalized. Colocalization for small patches could not be reliably determined 
as these patches or bright spots are below resolution. When having both labeled granulysin on 
the bilayer a FRET emission signal with excitation / emission at 488 nm / 620 nm could be 
detected (Figure 5F). Analyzing the signals (excitation / emission 488 nm / 520 nm and 488 
nm / 620 nm) over time after adding granulysin Alexa Fluor 594 an immediate increase of the 
signal at excitation / emission 488 nm / 620 nm occurred with a concomitant decrease in 488 
nm / 520 nm (Figure 5G). The increase of the FRET signal in seconds after adding granulysin 
Alexa Fluor 594 is an indication for an immediate oligomerization of granulysin after binding 
to the bilayer. This oligomerization is ongoing with the FRET signal increasing over the 
whole duration of the experiment. 
Oligomerization of Granulysin on Prokaryotic and Eukaryotic Membranes 
Granulysin was shown not to permeabilize eukaryotic membranes (Barman et al., 2006) 
despite the substantial amount that is bound by these membranes. To see if oligomerization is 
a prerequisite for permeabilization we performed a FRET experiment using vesicles made of 
E. coli and erythrocyte membrane lipid extracts. Respective vesicles were first measured with 
granulysin labeled with Alexa Fluor 488 followed by granulysin labeled with Alexa Fluor 594 
(Figure 6). The results showed a positive FRET peak in the spectrum at 620 nm (excitation at 
490 nm) for both prokaryotic and eukaryotic membranes., The FRET signal for granulysin 
molecules bound to E. coli membranes (Figure 6A) was considerably more pronounced than 
the FRET signal for granulysin in contact with erythrocyte membranes (Figure 6B) even 
when initial fluorescent signals at 490 nm / 520 nm were comparable. This implies that 
granulysin oligomerizes on both prokaryotic and eukaryotic membranes but to a lower extent 
on eukaryotic membranes. This correlates with the fact that granulysin is not able to induce 
defects on eukaryotic membranes.  
Detection of the Oligomers bound to the Phospholipid Membranes 
To further proof stable oligomers formation by granulysin , negatively charged cholesterol 
containing vesicles (POPG:DPPC:Cholesterol 1:1:1) were incubated for 1 hour together with 
54
1 µM granulysin. The sample was subsequently analyzed by by western blotting under 
reducing and non reducing conditions. In reducing sample buffer, granulysin is detected as a 9 
kDa large protein (Figure 6, lane A), whereas the sample with non-reducing sample buffer 
showed oligomers of various sizes (Figure 6, lane B). This further proves that granulysin 
forms stable, detergent insoluble oligomers after binding to a negatively charged membrane. 
Discussion 
Many small antimicrobial proteins, which bind to the bacterial membrane and kill the bacteria 
by lysis of the membrane, will not be able to actively penetrate the bacterial membrane unless 
the concentration of the protein is high enough to form oligomers (Walev et al., 1995). We 
showed recently that granulysin, one of these small antimicrobial proteins, is able to cause 
defects on prokaryotic membranes and on negatively charged cholesterol free bilayers 
mimicking prokaryotic membranes (Barman et al., 2006). Granulysin destroys intracellular 
bacteria, such as L. innocua, after binding to and uptake via lipid rafts by the target cell 
(Walch et al., 2005). Taken these results together the mechanism of uptake and killing of 
bacteria by granulysin must fulfill the following criteria: 1. ensure that no premature killing of 
the infected cell occurs during uptake which would result in release and further spreading of 
intracellular bacteria. 2. guarantee that granulysin is transferred to and kills the intracellular 
bacteria.  
Granulysin binds in a concentration dependent manner to negatively charged cholesterol 
containing membranes, typically found in eukaryotic cells (Barman et al., 2006). As we could 
show is the association of granulysin at high concentrations with negatively membranes of all 
compositions very fast. The association is slower for lower concentrations of granulysin. 
Regardless of the starting concentration and the high positive charges on granulysin a 
substantial amount of granulysin is not irreversibly bound neither by eukaryotic nor 
prokaryotic membranes. The binding to the cell eukaryotic cell membrane needs to be 
reversible, for subsequent binding and permeabilization of the bacterial membrane. Using 
surface plasmon resonance we could clearly demonstrate that a part of the protein remains in 
solution but also that a part of the protein stays permanently bound to the membrane.  
The structurally related protein saposin C has been shown using the atomic force microscope 
to disturb the organization of the lipids in the bilayers. It binds to the bilayers and 
progressively recruits additional saposin C molecules to penetrate the membrane, which leads 
to membrane restructuring (You et al., 2003; You et al., 2004). This correlates with our 
results, showing a loss of lipids when the bilayers are treated with saposin C as detected in the 
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biacore. Streptolysin O, which binds to the cholesterol in the membrane (Shany et al., 1974) 
showed in comparison to granulysin a stronger binding to the cholesterol containing 
membrane, when after the dissociation period, most of the protein was still bound to the 
membrane. This suggests that a large fraction of streptolysin O is irreversibly bound to the 
membrane, which supports the idea of the oligomerization, where the oligomers do not detach 
from the membrane once bound.  
Similar to other cationic proteins of the SAPLIP family, the three dimensional structure of 
granulysin does not predict pore formation (Anderson et al., 2003). Anderson et al. propose a 
model for the mechanism of action for granulysin, where each granulysin molecule binds to 
its neighbouring molecules, applying local forces to a part of the membrane (Anderson et al., 
2003). This model correlates with the carpet model, where protein molecules covers the 
infected cell by first binding to the membrane using electrostatic interactions and, second, 
permeabilization of the membrane is induced only where the protein concentration is high 
enough (Anderson et al., 2003; Pouny et al., 1992; Shai, 1999). This is in agreement with our 
previous results, where we were able to show using the atomic force microscope that 
granulysin molecules forms areas of defects on the surface of the bilayers (Barman et al., 
2006). These defects could originate from oligomerized granulysin molecules, that 
permeabilized membranes as proposed by Anderson et al. (Anderson et al., 2003). Measuring 
FRET after incubating labeled granulysin with Alexa Fluor 488 or 594, respectively, to 
membranes further indicates that the proposed mechanism of binding with subsequent 
oligomerization leads to permeabilization. The oligomers are formed on negatively charged 
phospholipid vesicles, as well as on eukaryotic and prokaryotic membranes. On prokaryotic 
membranes the oligomerization is more efficient than on eukaryotic membranes, which is 
crucial for granulysin to be able to permeabilize bacterial membranes, but not to harm the 
target cell membrane. 
From this data we conclude that granulysin binds to eukaryotic membranes, mostly in a 
monomeric form, but can also form oligomers, is endocytosed to reach the compartments with 
intracellular bacteria. Then the monomeric, reversible bound fraction of granulysin binds to 
the prokaryotic membranes, oligomerizes on their surface and finally permeabilizes the 
bacterial membrane leading to lysis of the intracellular bacteria. 
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Figure 1. (A) The concentration dependent binding of granulysin to the negatively charged test surface 
(POPG:DPPC:Cholesterol 1:1:1) in relationship to the uncharged control surface 
(POPC:DPPC:Cholesterol 1:1:1) is shown by surface plasmon resonance on a L1 chip using a Biacore 
3000. The highest concentration of granulysin, 10 µM (solid line) showed the highest binding to the 
membrane, in comparison to 1 µM granulysin (dashed line), 0.1 µM granulysin (gray line) and the 
control protein actin-fragment at a concentration of 10 µM (dotted line). (B) The graph shows the 
sequential binding of 1 µM granulysin added three times to the negatively charged surface 
(POPG:DPPC:Cholesterol 1:1:1) in relationship to the uncharged control surface 
(POPC:DPPC:Cholesterol 1:1:1).
0 100 200 300 400
0
1000
2000
3000
4000
Time (s)
R
es
po
nc
e 
U
ni
ts
Figure 2. The binding of granulysin to the erythrocyte membranes (dotted line) and Escherichia coli 
membranes (solid line) in relationship to the uncharged phospholipid vesicles 
(POPC:PDDC:Cholesterol 1:1:1) is shown by surface plasmon resonance on a L1 chip using a Biocore 
3000. Granulysin at the concentration of 10 µM is able to bind to both erythrocyte and E. coli
membranes, with a higher affinity to the bacterial membranes.
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Figure 3. The binding of Saposin C (A) and Streptolysin O (B) to the negatively charged test surface 
(POPG:DPPC:Cholesterol 1:1:1) in relationship to the control surface (POPC:DPPC:Cholesterol 1:1:1) 
for Saposin C and (POPG:DPPC 1:2) for Streptolysin O is shown by surface plasmon resonance on a L1 
chip using a Biacore 3000. Saposin C (10 µM) clearly removes lipids from the bilayers, which is shown 
by the negative response in the sensogram, whereas Streptolysin O (2500 U/ml) binds to the cholesterol 
containing membrane.
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Figure 4. The oligomerization of granulysin was studied using FRET experiments and granulysin 
molecules labelled with either Alexa Fluor 488 or Alexa Fluor 594. A. The dotted line shows the 
emission spectrum for granulysin coupled with Alexa Fluor 488 together with negatively charged 
vesicles (POPG:DPPC:Cholesterol 1:1:1) revealing a peak at 520 nm, and the solid line shows an 
emission peak at both 520 nm and 620 nm, reveals a FRET signal when both Alexa Fluor labelled 
proteins were present. B. Shows the same experimental conditions as in A performed in a buffer 
solution, revealing that granulysin does not oligomererize in absence of a membrane.
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Figure 5. (A) shows the Alexa Fluor 488 coupled granulysin (G-488) bound to the bilayer (λex= 490, 
λem=520), (B) and (C) shows the same bilayer at the emission wavelenght of 620 nm and the excitation 
wavelenght at 594 nm and 488 nm, respectively. (D) indicates the signal for G-488 at the timepoint after 
adding granulysin with AlexaFluor 594 (G-594), wheras (E) and (F) shows the same bilayer at the 
emission wavelenght of 620 nm and the excitation wavelenght at 594 nm and 488 nm, respectively, 
indicating the FRET signal in figure (F). The size of the images are 0.5 μm x 0.5 μm.  (G) shows the 
FRET signal of G-594 measured at emission 620 nm after excitation only at 490 nm is shown in gray. 
The signal is rising over time, revealing that the protein is oligomerizing on the membrane. The black 
line shows the excitation signal for G-488 recorded at the emission wavelength 520 nm.
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Figure 6. The oligomerization of granulysin on prokaryotic (A) and eukaryotic (B) membranes was studied 
using FRET experiments and granulysin molecules labelled with either Alexa Fluor 488 or Alexa Fluor 
594. The dotted line shows the spectrum for granulysin with Alexa Fluor 488 with a peak at 520 nm, and 
the solid line shows the FRET signal at 620 nm when both Alexa Fluor labelled proteins are present. The 
clear difference in the FRET signals of the membrane types is shown in (C), with three times higher signal 
at the procaryotic membranes, revealing a more extent oligomerization on E. coli membranes. 
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Figure 7. The stable oligomers of granulysin on negatively charged vesicles (POPG:DPPC:Cholesterol 
1:1:1) were shown by reducing (left) and non-reducing (right) SDS-PAGE followed by western blotting. 
The stable oligomers of the non-reduced samples are shown in B. 
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 DISCUSSION 
In this study we focused on the membrane binding, activity and oligomerization of the 
antimicrobial protein granulysin. Membrane active and pore forming toxins, such as 
amoebapores from the parasite Entamoeabe histolytica, are broadly distributed proteins, 
which form lesions and pores in membranes (Bruhn & Leippe, 1999; Bruhn et al., 2003). 
Amoebapores, as well as NK-lysin, belong to the same SAPLIP family as granulysin, sharing 
the particular three dimensional structure with a positively charged surface and their ability to 
interact with lipids (Bruhn et al., 2003; Sordillo et al., 2005). However, these proteins display 
differences in their mechanisms of action. All these proteins possess membrane perturbing 
and antimicrobial activity, which permit the defence against invading pathogens (Hecht et al., 
2004; Kaspar et al., 2001). One of the most prominent differences of these proteins is the pH 
dependency of their activity. NK-lysin is pH-independent, whereas the activity of both 
granulysin and amoebapores is significantly reduced at pH-values higher than pH 6. 
Amoebapores are not able to oligomerize at high pH-values (Andra et al., 2007; Winkelmann, 
Leippe & Bruhn, 2006). This could also be the case for granulysin, which is dependent on the 
ability to form oligomers for its membrane perturbing activity. 
Our finding revealing that granulysin is more active at lower pH values implies that the 
protein is perfectly adapted for its intracellular role while travelling along the endocytotic 
pathway (Barman et al., 2006). Granulysin is able to bind reversibly to the infected host cell 
membrane using the negative charges on the surface, but is only partly able to oligomomerize 
and therefore cannot permeabilize the eukaryotic membrane (Barman et al., 2006; Sundstrom, 
In Progress). Instead, granulysin is taken up via the lipid raft mediated endocytotic pathway, 
where the pH dependency plays an important role for the function and activity of granulysin 
(Barman et al., 2006; Walch et al., 2005). The pH in the endocytosis compartments changes 
from 5.9-6.0 in early endosomes to 5.0-6.0 in late endosomes to 5.0 in lysosomes (Geisow & 
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 Evans, 1984; Renswoude et al., 1982), which converts granulysin from lower activity to a 
highly active protein at low pH in the later stages of endocytosis. This pH dependency of 
granulysin leads to increased activity and promotes the binding to prokaryotic membranes and 
killing of intracellular pathogens, such as L. innocua and M. tuberculosis, which travel along 
the same route, namely from endosomes via phagosomes to phagolysosomes (Gaillard et al., 
1987), where they can be efficiently lysed by granulysin (Walch et al., 2005). Our data also 
indicate that the protection from lysis of the endosomal compartments may stem from the 
lipid composition and the cholesterol content of these membranes and, therefore, we suggest 
this to be part of a mechanism for inhibiting the permeabilization by granulysin (Barman et 
al., 2006).  
To reach the intracellular bacteria, granulysin needs first to bind reversibly to the eukaryotic 
cell membrane. On the host cell membranes lipid rafts, which are highly concentrated in the 
regions of the immunological synapse (Xavier et al., 1998), the fraction of granulysin that is 
tightly bound and oligomerized, applies local stress that might trigger budding and 
subsequently endocytosis of granulysin-containing membrane vesicles. Subsequently 
granulysin is able to reach the intracellular bacteria and bind to their membranes. The 
difference in packing in lipid raft versus non-lipid raft parts of the membrane is due to the 
saturation of the hydrocarbon chains in raft sphingolipids and phospholipids as compared with 
the unsaturated state of fatty acids of phospholipids in the liquid-disordered phase. This leads 
to a highly rigidized membrane structure, with important functions in the uptake and viability 
of the cell, and also protects the host cell membrane from granulysin mediated lysis (Crane & 
Tamm, 2004; Simons & Vaz, 2004). 
After cholesterol-dependent uptake via lipid rafts, granulysin is transported to early sorting 
endosomes as indicated by the colocalization with the early endosomal antigen 1, fusing later 
with phagosomes and lysosomes, and finally lysing the intracellular bacteria. At the same 
time secreted IFN-γ at locations of infection by the CTLs would enhance the targeting of 
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 granulysin to the Listeria containing phagosomes. There is some evidence that IFN-γ triggers 
upregulation of the small rab5 GTPase in activated macrophages and therefore enhances 
phagosome maturation (Alvarez-Dominguez 1998; Via 1998). Fusion of granulysin 
containing early endosomes with phagosomes may be regulated by rab5 and directly 
correlated with an accelerated maturation of Listeria containing phagosomes. This will further 
increase the efficiency of granulysin mediated killing of intracellular bacteria (Alvarez-
Dominguez 1999). 
Granulysin is also able to kill bacteria in suspension. Our results of the killing of Listeria 
innocua grown in suspension (Walch et al., 2005) are in agreement with data obtained in 
other workgroups using a variety of microbial pathogens including Listeria monocytogenes 
(Stenger, 1998, Ernst 2000). The binding of granulysin to bacterial membranes is shown here 
for the first time (Walch et al., 2005) and is explained by the multitude and the distribution of 
positive charges of granulysin (net charge +11 at neutral pH), and on the other hand, the 
composition of the prokaryotic and eukaryotic membranes containing acidic phospholipids, 
such as phosphatidylglycerol and cardiolipin in prokaryotic membranes as well as additional 
cholesterol in eukaryotic membranes (Gidalevitz et al., 2003; Kurz et al., 2005; Pomorski et 
al., 2004). The positive charges from the arginine residues of the granulysin molecule attract 
the protein to the negative charges in the membrane phosphates. 
The charges on the surface of granulysin are essential for the binding to both the eukaryotic 
and to the prokaryotic membrane, and the fact that eukaryotic membranes contain cholesterol 
(Albert & Boesze-Battaglia, 2005; Ohvo-Rekila et al., 2002; Slotte, 1999) does not inhibit the 
binding of the protein, indicating that granulysin is able to effectively bind to both the host 
cell membrane and the bacterial membrane, which is of importance for an effective lysis of 
intracellular bacteria. Granulysin binds to and permeabilizes prokaryotic membranes in a 
concentration dependent manner, which suggests a cooperative action of the granulysin 
(Barman et al., 2006; Sundstrom, In Progress). This cooperative action of granulysin has also 
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 been suggested by Anderson et al. (2003), who describe that many granulysin molecules may 
come together to form the membrane lesions, which leads to a scissoring motion of granulysin 
to further expose the lytic surface of the molecule on the prokaryotic membrane (Anderson et 
al., 2003). 
Other positively charged toxins are defensins, which also belong to the family of pore 
forming toxins. They are secreted by activated neutrophils, and their mechanism of action 
correlates to granulysin. These small cationic toxic peptides, which after release from the 
granules of neutrophils, bind to the target cell membrane in a charge dependent manner, but in 
contrast to granulysin, defensins induces an ion flux by pore formation (Sahl et al., 2005). 
These peptides also show a great difference in the mechanism of action against prokaryotic 
and eukaryotic membranes, which is thought to be due to the greater capacity of the 
eukaryotic cells for membrane repair (Bals & Hiemstra, 2004; Lichtenstein et al., 1988), but 
as shown in our results, the mechanism for the defence against antimicrobial proteins of the 
eukaryotic cell membrane could be due to the differences in the eukaryotic and prokaryotic 
membranes.  
In general, the resistance of eukaryotic membranes against membrane active and pore forming 
proteins can be due to the absence of a high affinity binding site, the capacity to repair lesions 
and the inhibition of the insertion of the pore forming domains despite the assembly of 
oligomers (Valeva et al., 2000). We clearly showed that cholesterol is the component 
preventing the permeabilization and partly the oligomerization of granulysin on membranes, 
due to the tighter membrane packing and rigidity of the lipid rafts as well as the non lipid raft 
part of the membrane, and therefore works as a protector for the antimicrobial effect against 
eukaryotic cells. Prokaryotic membranes do not contain cholesterol and allow oligomerization 
of granulysin in a higher extent than on eukaryotic membranes, and are therefore lysed by the 
granulysin oligomers. Also other membrane active proteins, such as listeriolysin O, have 
shown to oligomerize to perform its action intracellularly. The enhanced activity of 
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 listeriolysin O at low pH and low cholesterol concentrations reveals a toxin completely 
adapted for its intracellular role in mediating escape of bacteria from the phagosomes (Bavdek 
et al., 2007). 
The mechanism of action of granulysin differs from the other lytic proteins released from the 
acidic granules of CTLs and NK cells. The active form of perforin also binds in a monomeric 
form to the cell membrane, but not charge dependently, instead using the phosphatidylcholine 
as a receptor for binding. After the binding, also perforin forms oligomers on the membrane, 
but instead of lipid raft dependent endocytosis, perforin forms pores on the target cell 
membrane, where granzymes and granulysin can enter (Keefe et al., 2005; Tschopp et al., 
1989). The perforin induced cell death is a result of osmotic lysis or the influx of Ca2+ ions 
(Liu et al., 1995a; Liu et al., 1989). Granzyme B on the other hand is able to bind to the target 
cell membrane using charges, but it cannot induce target cell death without the presence of 
perforin, because it is needed for the intracellular delivery of granzyme B (Giesubel et al., 
2006; Kurschus et al., 2004). In contrast, granulysin can enter the target cell and lyse 
intracellular bacteria without the presence of perforin (Walch et al., 2005). 
The entering of granulysin through the eukaryotic membrane can be explained by the 
reversible binding of granulysin on the host cell membrane. Granulysin oligomerizes on 
negatively charged membranes, and on eukaryotic and prokaryotic membranes, but in a lower 
extent on eukaryotic membranes, which indicates the reversible binding to eukaryotic 
membranes where only a minor fraction is oligomerized, and the monomeric fraction of the 
protein continues through the endocytotic pathway towards the intracellular bacteria, binds 
and oligomerizes on their surface, and finally permeabilizes the bacterial membrane, leading 
to lysis. This finding is of importance for understanding how granulysin binds to the host cell 
membrane, is endocytosed and then is capable to bind again to the bacterial membrane, 
leading to lysis of the intracellular bacteria. 
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 Also other toxins, such as Staphylococcus α enterotoxin, are secreted and bind to the target 
membrane in a monomeric form. First oligomeric pre-pores are formed, and only when the 
pore forming sequence of the toxin is inserted into the bilayers a pore can be formed. The 
oligomeriozation of this toxin is allowed on lipid rafts, whereas the fraction of the toxin that is 
bound outside of this microdomain in a monomeric form are only transiently bound to the 
membrane, correlating to the membrane binding activity of granulysin on eukaryotic 
membranes (Valeva et al., 2006). 
This study provides important information for understanding the function, activity and the 
mechanism of action of granulysin and other positively charged antimicrobial proteins. We 
give an insight how they interact with eukaryotic versus prokaryotic membranes and also an 
explanation why eukaryotic membranes are protected from being lysed by granulysin as well 
as the mechanism how granulysin is able to reach and kill intracellular bacteria. 
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 CONCLUSIONS 
Based on these results we conclude that granulysin binds transiently to the infected host cell 
membrane using electrostatic interactions, but is able to only partly oligomerize on these 
membranes. The transiently bound fraction of granulysin enters the cell via lipid raft mediated 
endocytosis and is transferred via early and late endosomes and then fusing with bacteria-
harbouring phagosomes and lysosomes, the compartments were intracellular bacteria are 
located.  
The pH value in the endocytotic compartments gets gradually more acidic, leading to a higher 
activity of granulysin due to the more positively charged surface. Granulysin binds then to the 
negatively charged bacterial membrane, oligomerizes to be able to add local forces on the 
membrane and to finally permeabilize the bacteria leading to lysis.  
The cholesterol content of the host cell membrane plays a particularly important role in the 
potential of granulysin to perturb the membrane. Not only lipid rafts but also non-raft parts of 
the eukaryotic membrane contain cholesterol and are therefore not permeabilized. This seems 
to be a protective property of the eukaryotic membrane. The infected host cell takes up 
granulysin through the cholesterol enriched lipid rafts and transports the lytic protein to the 
intracellular bacteria. This mechanism is illustrated in Figure 3.  
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Figure 3. The mechanism of granulysin-mediated killing. (A) Granulysin molecules are released 
during granule exocytosis from activated CTLs or NK cells (1). Granulysin binds to the lipid 
rafts on the infected target cell membrane (2) and is endocytosed via early and late endosomes 
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(4,5) to phagosomes and lysosomes (6,7). (B) The pH value is more acidic in the later 
compartments of endocytosis, leading to an increased binding of the active endocytosed 
granulysin (8) to the intracellular bacterial membranes (9). Granulysin oligomerizes (10) and 
permeabilizes the cholesterol free bacterial membrane leading to lysis and killing of the bacteria 
(11). 
 
 
 FURTHER STUDIES 
To continue with the study of how granulysin interacts and permeabilizes membranes, 
circular dichroism (CD) could be used to investigate the conformational changes of the 
protein when it binds to eukaryotic versus prokaryotic membranes. Since the oligomers of the 
granulysin molecules could only bee shown by FRET experiments, due to the resolution 
limitations of the AFM, the CD technique would give valuable information about the 
differences in binding and acvtivity of granulysin on different membranes. 
The binding and activity of the protein could also be tested on membranes extracted from 
different bacteria, e.g Chlamydia pneumoniae and Mycobacterium tuberculosis.  
Finally, a computer simulated model showing how the protein interacts with and binds to 
membranes could be completed. 
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